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There is a long history of health claims concerning living microorganisms in food, 
particularly lactic acid bacteria. In a Persian version of the Old Testament (Genesis 18:8) it 
states that "Abraham owed his longevity to the consumption of sour milk." In 76 BC the 
Roman historian Plinius recommended the administration of fermented milk products for 
treating gastroenteritis. (Bottazzi V., 1983) Since the advent of the microbiology era, some 
investigators (Carre C., 1887), (Tissier H., 1984), (Metchnikoff E., 1907) attributed such 
health effects to shifts of the intestinal microbial balance. Metchnikoff claimed that the intake 
of yogurt containing lactobacilli results in a reduction of toxin-producing bacteria in the gut 
and that this increases the longevity of the host. Tissier recommended the administration of 
Bifidobacteria to infants suffering from diarrhea, claiming that Bifidobacteria supersede the 
putrefactive bacteria that cause the disease. (Tissier H., 1984)
Rettger et al., (Rettger L.F., Cheplin H.A., 1921, Rettger L.F., et al., 1935) and 
Kopeloff (Kopeloff 1926) showed that Lactobacillus acidophilus may survive in the human 
gut but the "Bulgarian bacillus" did not. 
The significant role of the intestinal microflora for resistance to disease was shown by 
Bohnhoff et al., (Bohnhoff N., et al., 1954), Freter (Freter R. 1954, 1955, 1956), and Collins 
and Carter. (Collins F.M., Carter P.B., 1978) Oral administration of antibiotics to mice 
rendered the animals more susceptible to infection with Salmonella typhimurium, Shigella 
flexneri, and Vibrio cholerae. Thus, ≤1x101 Salmonellae enteritidis were sufficient to kill 
germ-free guinea pigs, whereas 1x109 bacteria were required to kill animals with complete 
intestinal microflora. 
Thus it can be observed that microbial cultures have been used for thousands of years in 
food and alcoholic fermentations, and in the past century have undergone scientific scrutiny 
for their ability to prevent and cure a variety of diseases. Elie Metchnikoff in 1907 first 
introduced the probiotics concept when he observed the long life of Bulgarian persons who 
consumed fermented milk foods. He suggested that lactobacilli might counteract the 
putrefactive effects of gastrointestinal metabolism.
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NORMAL INTESTINAL MICROFLORA
In a healthy animal, the internal tissues, e.g. blood, brain, muscle, etc., are normally 
free of microorganisms. However, the surface tissues, i.e., skin and mucous membranes are 
constantly in contact with environmental organisms and become readily colonized by various 
microbial species. 
The mixture of organisms regularly found at any anatomical site is referred to as the 
normal flora, except by researchers in the field who prefer the term "indigenous microbiota".
 Resident Microbiota 
 Transient Microbiota 
 Opportunistic Microbiota 
The normal flora of humans consists of a few eukaryotic fungi and protists, but 
bacteria are the most numerous and obvious microbial components of the normal flora. The 
human body is made up of about 10 trillion cells, but it hosts 100 trillion more microbes as 
normal flora. The vast majority of cells living on and in the body are bacteria and few are 
other microbes. 
Intestinal colonization acts as an important antigenic stimulus for the maturation of 
the gut-associated lymphoid tissue. Capacity to generate IgA producing cells progressively 
increases in response to intestinal antigenic stimulation, particularly the establishment of the 
gut microflora, The range of non digestible molecules (prebiotics) that beneficially affect the 
host by selectively stimulating the growth or activity of one or a limited number of bacterial 
species in the colon, and thus improve host health can be of great value.
ALTERATION OF NORMAL INTESTINAL MICROFLORA 
Various factors affect the gut microflora during diarrhoea, chronic illness and 
treatment with antibiotics, chemotherapy, steroids and even after surgery. There is a potential 
loss of normal flora and live bacterial food supplement which beneficially affect the host by 
improving its intestinal microbial balances. This changes the balance of normal intestinal 
flora in favour of pathogen. (Collins M.D., et al., 1999) Microbial metabolites may possess 
genotoxic, mutagenic or carcinogenic activity and contribute subsequently to the 
development of cancer. (Fuller R., 1989)
A huge and diverse range of bacterial species colonize the human body. The 
microbiota extends from mouth to anus and into the vaginal tract of women. They also reside 
on the skin. Many lines of research have demonstrated the significant role of the microbiota 
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in human physiology. The microbiota is involved in the healthy development of the immune 
system, prevention of infection from pathogenic or opportunistic microbes and maintenance 
of intestinal barrier function. For a variety of reasons, normal native bacteria may not always 
perform these functions optimally. Probiotics and prebiotics have been studied and used to 
improve these function.
Recent management of infectious disease and research work has focused on the 
gastrointestinal tract. The human intestinal microflora is an important constituent in the 
intestine’s mucosal barrier and has therapeutic role. The first known microbes used for this 
purpose was specifically known as probiotics called lactobacillus. (Gibson G.R., Roberfroid 
M.B., 1995)
To generalize, it is possible to categorize the gut microbiota components on the basis 
of whether they exert potentially pathogenic or health promoting aspects. Lactic acid 
producing genera such as the Bifidobacteria or lactobacilli have a long standing association 
with health. These bacteria can be increased either by feeding appropriate strains as a 
probiotic or through the provision of prebiotic growth substrates. The rapidly expanding 
research support and product availability for probiotics and prebiotics is evidence for their 
growing popularity.
The history of probiotics began with the history of man by consuming fermented 
foods that is well known. (Gismondo, et al., 1999, Guarner et al., 2005) In 1908 a Russian 
researcher Ellie Metchnikoff, who won a Nobel Prize, firstly proposed the beneficial effects 
of probiotic microorganisms on human health. Metchnikoff hypothesized that Bulgarians are 
healthy and long lived people because of the consumption of fermented milk products which 
consists of rod shaped bacteria (Lactobacillus spp.). Therefore, these bacteria affect the gut 
microflora positively and decrease the microbial toxic activity. (Gismondo, et al., 1999, 
Çakır 2003, Chuayana, et al., 2003 )
Microbial cultures have been used for thousands of years in food and alcoholic 
fermentations, and in the past century have undergone scientific scrutiny for their ability to 
prevent and cure a variety of diseases. Elie Metchnikoff in 1907 first introduced the 
probiotics concept in 1908, when he observed the long life of Bulgarian peasants who 
consumed fermented milk foods. He suggested that lactobacilli might counteract the 
putrefactive effects of gastrointestinal metabolism. The concept of probiotics has evolved 
from the work of Metchnikoff (1908) although the term was probably first used by Lilly & 
Stillwell (1965).
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The term probiotic, meaning "for life," is derived from the Greek language. It was 
first used by Lilly and Stillwell (Lilly D.M, Stillwell R.H., 1965) in 1965 to describe 
"substances secreted by one microorganism which stimulates the growth of another" and thus 
was contrasted with the term antibiotic. It may be because of this positive and general claim 
of definition that the term probiotic was subsequently applied to other subjects and gained a 
more general meaning. In 1971 Sperti (Sperti G.S., 1971) applied the term to tissue extracts 
that stimulate microbial growth. Parker (Parker R.B., 1974) was the first to use the term 
probiotic in the sense that it is used today. He defined probiotics as "organisms and 
substances which contribute to intestinal microbial balance." Retaining the word substances
in Parker's definition of probiotics resulted in a wide connotation that included antibiotics. In 
1989 Fuller (Fuller R., 1989) attempted to improve Parker's definition of probiotic with the 
following distinction: "A live microbial feed supplement which beneficially affects the host 
animal by improving its intestinal microbial balance." This revised definition emphasizes the 
requirement of viability for probiotics and introduces the aspect of a beneficial effect on the 
host, which was, according to his definition, an animal. In 1992 Havenaar et al., (Havenaar 
R., Huis In't Veld MJH., 1992) broadened the definition of probiotics with respect to host 
and habitat of the microflora as follows: "A viable mono- or mixed culture of 
microorganisms which applied to animal or man, beneficially affects the host by improving 
the properties of the indigenous microflora." Salminen (Salminen S., 1996) and Schaafsma 
(Schaafsma G., 1996) broadened the definition of probiotics even further by no longer
limiting the proposed health effects to influences on the indigenous microflora. According to 
Salminen, a probiotic is "a live microbial culture or cultured dairy product which beneficially 
influences the health and nutrition of the host." According to Schaafsma, "Oral probiotics are 
living microorganisms which upon ingestion in certain numbers, exert health effects beyond 
inherent basic nutrition." 
There are two aspects in Salminen's definition that in our opinion need revision. First, 
the definition given by Salminen includes beneficial influences on "nutrition of the host" in 
addition to health effects. It is not clear what the term nutrition should imply in this context, 
which would not be covered by the term health. Major effects on nutrition also imply effects 
on health, whereas minor alterations are of no relevance to the definition "for life." Therefore, 
the term nutrition might be best omitted from the definition. 
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In contrast with previous definitions, Salminen's definition (Salminen S., 1996)
considers cultured dairy products and microbial cultures to be probiotic. Indeed the matrix of 
a product may affect the activity of microbes and therefore the survival and effect of the 
microbes, and thus deserves consideration. However, because nondairy products, (eg, 
sauerkraut, fermented cereals and other plant-based foods, and salami) may contain viable 
probiotic microorganisms [eg, Lactobacillus plantarum (Molin G., 2001)], the limitation of 
the definition to dairy products is not justified. Furthermore, cultured dairy products include 
products that are cultured and then pasteurized or sterilized, which results in the loss of viable 
microorganisms. In fact there is evidence for health effects beyond nutritional value of such 
products, eg, anticarcinogenic and immunomodulating effects have been exerted by yogurt 
fractions and cell-wall components of lactobacilli and bifidobacteria. (Sekine K, et al., 1985, 
Farmer RE, Shahani KM, Reddy GV., 1987, Steward-Tull DES., 1980, Okutomi T, et 
al., 1990)
Abandoning the viability of microorganisms or omitting the survival of the microbes 
and their effects on the indigenous microflora as prerequisites for the claim probiotic has 
consequences for what may be called probiotic. The definitions given by Salminen 
(Salminen S., 1996) and Schaafsma (Schaafsma G., 1996) would include yogurt containing 
usual cultures (Streptococcus thermophilus and Lactobacillus delbrüecki, subsp. bulgaricus) 
because these cultures may compensate for lactase insufficiency in lactose maldigestion. (de 
Vrese M., et al., 2001) This substitution may be even more pronounced when bacteria that 
do not survive in the small bowel are ingested and release their ß-galactosidase into the upper 
intestine. This substitution may as well be achieved by bacteria that have been killed by 
irradiation, which leaves their cell walls intact and therefore enables protection during gastric 
transit.(de Vrese M., et al., 2001)
World Health Organization: 
“Live microorganisms which when administered in adequate amounts confer a health 
benefit on the host”.
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IDEAL PROPERTIES OF PROBIOTICS
 The probiotics must exert beneficial effect on the host 
 The probiotic must be non-pathogenic and non-toxic 
 The probiotics must contain a large number of viable cells 
 The probiotic must be capable of surviving and metabolizing in the gut 
 The probiotic must remain viable during storage and use ( Rolfe, R. 
            D., 2000)
HEALTH EFFECTS 
The health effects attributed to the use of probiotics are numerous. The following 
outcomes are well documented: 1) lower frequency and duration of diarrhea associated with 
antibiotics (Clostridium difficile), rotavirus infection, chemotherapy, and, to a lesser extent, 
traveler's diarrhea; 2) stimulation of humoral and cellular immunity; and 3) decrease in 
unfavorable metabolites, eg, amonium and procancerogenic enzymes in the colon. There is 
some evidence of health effects through the use of probiotics for the following: 
1. reduction of Helicobacter pylori infection; 
2. reduction of allergic symptoms; 
3. relief from constipation; 
4. relief from irritable bowel syndrome; 
5. beneficial effects on mineral metabolism, particularly bone density and stability; 
6. cancer prevention; and 
7. reduction of cholesterol and triacylglycerol plasma concentrations (weak evidence). 
Numerous effects can hardly be explained by a unifying hypothesis that is based on a 
single quality or mechanism and remains valid for all microorganisms exerting one or the 
other effect.
Antimicrobial activities of probiotics include the 
(1) Production of bacteriocins/defensins, 
(2) Competitive inhibition with pathogenic bacteria,
(3) Inhibition of bacterial adherence or translocation,and
(4) Reduction of luminal pH. Probiotic bacteria can also enhance intestinal barrier function 
by increasing mucus production.
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Probiotics have several mechanisms of action to protect the host against intestinal disease it 
given as follows: 
1. Antimicrobial activity
2. Colonization resistance 
3. Immune effects 
4. Antimutagenic effects
5. Antigenotoxic effects
6. Influence on enzyme activity
7. Enzyme delivery.
STRAIN CHARACTERISTICS AND HABITAT SPECIFICITIES 
Different strains of probiotic bacteria may exert different effects based on specific 
capabilities and enzymatic activities, even within one species. (Ouwehand A.C., 1999, 
Bernet M.F., 1993)
Different microorganisms express habitat preferences that may differ in various host 
species.(Freter R., 1992) Lactobacilli are among the indigenous flora colonizing the 
chicken's crop, the stomach of mice and rats, and the lower ileum in man. Bacteria colonizing 
such high-transit-rate sites must adhere firmly to the mucosal epithelium (Savage D.C., 1972, 
Fuller R., 1973, Beachey EH., 1980) and must adapt to the milieu of this adhesion site. The 
competition for adhesion receptors between probiotic and pathogenic microorganisms, 
therefore, is dependent on such habitat specifics. 
On the other hand, bacteria are found in much higher numbers in the colon, 
particularly in the feces, than are lactobacilli. It is self-evident that effects bound to this 
luminal site of action may be exerted even more efficiently by such microorganisms, which 
do not necessarily need to adhere to the mucosa. Moreover, preferences for microhabitats 
have to be considered. Four microhabitats in the gastrointestinal tract were outlined by Freter 
(Freter R., 1992) as follows: 1) the surface of epitheliums cells; 2) the crypts of the ileum, 
cecum, and colon; 3) the mucus gel that overlays the epithelium; and 4) the lumen of the 
intestine. 
Introduction
8
Several indigenous, pathogenic, or probiotic microorganisms target the surface of the 
epithelium by specific adhesion, often mediated by special organelles, eg, fimbriae. (Beachey 
E.H., 1980, Gibbons R.J., 1975) The crypts are typically colonized by motile, spiral-shaped 
bacteria of the genera Borellia, Treponema, Spirillium (Lee A., 1980., Lee A., 1985) and 
others, eg, H. Pylori. (Blaser MJ., 1990) The mucus layer can form a microbial habitat and 
can protect the host against colonization in some circumstances. As a result of its complex 
and varying composition and for technical reasons, its function in this context is least 
clarified. 
The luminal content of bacteria depends greatly on bowel transit. Therefore, the 
microbial density in the small bowel is low, whereas it is abundant in the lumen of the colon, 
which gives space to microorganisms without adhesion molecules. 
When the great variety of species, strain characteristics, and the habitat specifics are 
considered, it becomes clear that a proven probiotic effect on a one strain or species can not 
be transferred to other strains or species. 
The term prebiotic was introduced by Gibson and Roberfroid (Gibson G.R., 1995)
who exchanged "pro" for "pre," which means "before" or "for." They defined prebiotics as "a 
non-digestible food ingredient that beneficially affects the host by selectively stimulating the 
growth and/or activity of one or a limited number of bacteria in the colon." This definition 
more or less overlaps with the definition of dietary fiber, with the exception of its selectivity 
for certain species. This selectivity was shown for bifidobacteria, which may be promoted by 
the ingestion of substances such as fructooligosaccharides and inulin ((Gibson G.R., 1995
Hidaka H., 1986, Gibson G.R., 1995), transgalactosylated oligosaccharides (Tanaka R., 
1983, Ito M., 1993, Rowland I.R., 1993), and soybean oligosaccharides. (Hayakawa K., 
1990, Saito Y., 1992)
The term synbiotic is used when a product contains both probiotics and prebiotics. 
Because the word alludes to synergism, this term should be reserved for products in which 
the prebiotic compound selectively favors the probiotic compound. In this strict sense, a 
product containing oligofructose and probiotic bifidobacteria would fulfill the definition, 
whereas a product containing oligofructose and a probiotic Lactobacillus casei strain would 
not. However, one might argue that synergism is attained in vivo by ingestion of lactobacilli 
on the one hand and promotion of indigenous Bifidobacteria on the other hand. 
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MECHANISM OF PROBIOTICS ACTIVITY
Probiotics exert their effects on the host but mechanisms are still speculative. The 
mechanism of action of Probiotics strain seems to be the manufacture of specific chemicals 
and from existing evidence appears to be strain specific. Enhancement of colonization 
resistance and/or direct inhibitory effects against pathogen is likely to be important mode of 
action in situations in which probiotics have reduced the occurrence and duration of 
gastrointestis They may antagonize pathogen directly through production of antimicrobial 
and antibacterial compounds such as Cytokines and Butyric acid ( De vuyst and  
Vandamme, 1994; Kailasapothy and Chin,2000) , reduce the gut pH by stimulating the 
Lactic acid to improve micro flora ( Langhendries et al., 1995), compete with pathogens for 
the binding to receptors at various sites  (Fujiwara 1997, Kailasapathy and Chin 2000)
The Probiotics appears to improve immune function and stimulate immune modular 
cells. (Isolauri et al., 1991 and 1995, Rolfe-2000) It produces lactose which aids in lactose 
digestion, compete for the nutrients and adhere to the sites on the gut wall and regulate 
colonocyte gene expression. (Eg. Expression of mucin genes) (Fooks and Gibson 2002, 
Mack 1999, Steer et al., 2000)
A Group of requirements have been identified for microorganisms to be defined as an 
effective probiotics. (Salminen et al., 1996) These are,
1) Adhere to cells
2) Exclude or reduce pathogenic adherence.
3) Persist and multiply.
4) Produce acids, peroxidases and bacteriocins antagonistic to pathogen growth.
5) Safe, non-invasic, non-carcinogenic and non-pathogenic.
6) Co- aggregate to form a normal balanced flora.
The summarized mechanisms underlying Probiotics activity could be:
1) Inhibit growth of potential pathogens by producing lactic acid, bactriocin etc..
2) Competitive exclusion of enteric pathogen.
3) Triggers cytokine synthesis from enterocytes by attaching to their surface.
4) Neutralization of dilatory carcinogens by the production of butyric acid.
5) Restore the normal intestinal flora during antibiotic therapy.
6) Produce toxic  metabolites e.g. H2O2  
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Probiotics are gaining importance because of the innumerable benefits e.g.
 Treating lactose intolerance.
 Hyper cholesterol problem.
 Cardiac diseases and managing cardiac problems like Atherosclerosis, 
Arteriosclerosis.
Systematic Investigations should be made on the relation of gut microbes to the 
prevention of aging and on the influence of diets which prevent intestinal putrefaction in 
prolonging life and maintaining the forces of the body.
Probiotics offer an alternative to be used in place of or concurrently with conventional 
antimicrobials. Because of their relative safety, ease of use and excellent tolerability to bile’s,  
the use of Probiotics should be considered, not just as adjunctive replacement after antibiotic 
administration but as possible first line therapy when clinically indicated. Correct uses of 
Probiotics have been successful to enhance treatment of bacterial vaginosis, recurrent UTI, 
diarrhoea, cancer, competition with Antibiotic therapy, Dysbacteriosis and dislipidemis. Use 
of Probiotics appears to be a promising answer to current challenges experienced due to 
excessive use and development of tolerance of Antibiotics.
GI tract harbours a complex ecology of microorganisms. A good balance in 
microbiota promotes good gut health while disturbance in the micro ecosystem results in 
various gastrointestinal disorders. Probiotics supports the intestinal flora balance and their 
beneficial effect on various GI disorders (Ulcers, Lesions. H.pylori Infection, Inflammatory 
bowel diseases, irritable bowel syndrome, acute gastroenteritis,   maldigestion, lactose 
intolerance and colon cancer)
ADVANTAGES OF PROBIOTICS
Probiotics have many of advantages. These are not just true to old people but for 
young ones as well. Among a list of benefits of probiotics are the following things to take 
note of:
 Nourishment of the body. The hydrocarbon in our system can be stopped by 
probiotic bacteria. This results to easy break up of foods into simple components which 
permits nearly complete assimilation by the digestive structure. Thus, probiotics 
significantly augment complete nourishment and boost fast cellular progress and 
improvement. 
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 Clearing of the intestinal area. Probiotics has the ability to clear up our intestinal 
area by removing the accrued corrosion beneath the coating of crud in your intestinal 
partitions. They flush out the garbage from our intestines fully.
 Creation of essential enzymes. Probiotics are also useful in creating numerous 
essential enzymes and intensify the accessibility of some forms of vitamins and nutrients 
like vitamin K, lactase, fatty acids and calcium. 
 Strengthens the immune system. The helpful bacteria can also intensify the function 
of our immune system to alleviate the indications of allergies, recurring exhaustion 
condition and systemic candid. 
 Eliminates digestive disorders. In addition to the mentioned benefits, problem with 
constipation is rapidly alleviated with probiotics giving us regular bowel movements which 
also denote that diarrhoea problem is lessened. The friendly bacteria established in 
probiotics develop particular proteins that work as antigens. The pools of imprecise antigens 
obtainable in support of immune system are then utilized in combating majority of the 
distinctive illnesses in our digestive area. 
 Defers bacteria production. As soon as probiotics are linked up to our intestinal 
partitions, they start to develop a gentle acidic surrounding that defers the development of 
bacteria which cause illnesses. In this manner, probiotics also aid our immune system due to 
the fact that it is distributed inside the intestines while continuing its function on the 
different parts of our body. 
 Eliminates harmful toxins from the body. The microorganisms in probiotics work 
in harmony with the different tissues and organ cells to metabolize proteins and aid to get rid 
of poisonous excesses from our body. 
 Invigorates antibody development. Probiotics can also invigorate B-lymphocyte and 
other associated antibody development by producing large groups of additional antibodies 
all set to defend our body from toxic contamination. 
 Destruction of viruses. Lastly, the very useful bacteria can destroy viruses and 
parasites that endanger your overall health. 
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OBJECTIVES
The following objectives were set to be achieved through research:
 Isolation of Probiotics from various natural samples and their characterization in 
terms of morphology and biochemical activities.
 Study of effect of various factors like salt, pH. Bile salt and acids on isolated 
probiotics.
 Study of Growth pattern of probiotics isolates.
 Study of antimicrobial susceptibility of probiotics & its antimicrobial activity on other 
indigenous micro flora.
 Study of Growth of Probiotics isolates with Prebiotics.
 Study of possible mechanism of probiotics and synbiotics and its significance in their 
therapeutic evaluation.
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INTRODUCTION
Pasteur was the first to say that life of upper animals would be impaired by the 
absence of indigenous microorganisms but was his colleagues Metchnikoff who, exactly one 
century ago, to observe that: "the different susceptibilities of people to the harmful action of 
microbes and their products. Some can swallow without any evil result a quantity of microbes 
which in the case of other individuals would produce a fatal attack of cholera. Everything 
depends upon the resistance offered to the microbes by the invaded organism." (Metchnikoff
1907)
He also stated that "The dependence of the intestinal microbes on the food makes it 
possible to adopt measures to modify the flora in our bodies and to replace the harmful 
microbes by useful microbes." (Metchnikoff 1907)
This sentence describes in a clear way the "probiotic concept", the use of health 
promoting bacteria able to exert a positive role on intestinal flora, even if the word probiotics 
was coined several dozen years later; then we can assume today we are going to celebrate the 
first century of life of probiotics.
There is a tendency to regard all micro organisms as harmful; to equate bacteria with 
germs. Nothing could be further from the truth. The number of non pathogenic species far 
exceeds the number of pathogenic species and many of the non pathogens are in fact useful, 
even essential for the continued existence of life on earth.
Inside each of us live vast numbers of bacteria without which we could not remain in 
good health. There are several thousand billions in each person (more than all cells in the 
body) divided into four hundred species, most of them living in the digestive tract.
PROBIOTICS
Probiotics are defined as viable microbial dietary supplements that, when introduced
in sufficient quantities, beneficially affect human organism through their effects in the 
intestinal tract. (Dimer & Gibson 1998; Zimmer & Gibson 1998; Sanders 1998; Vaughan 
et al., 1999; Zubillaga et al., 2001; Holzapfel & Schillinger 2002)
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The physiological effects related to probiotic bacteria include the reduction of gut pH, 
production of some digestive enzymes and vitamins, production of antibacterial substances, 
e.g., organic acids, bacteriocins, hydrogen peroxide, diacetyl, acetaldehyde, lactoperoxidase 
system, lactones and other unidentified substances, reconstruction of normal intestinal 
microflora alter disorders caused by diarrhoeas, antibiotic therapy and radiotherapy, reduction 
of cholesterol level in the blood, stimulation of immune functions, suppression of bacterial 
infections, removal of carcinogens, improvement of calcium absorption as well as the 
reduction of faecal enzyme activity. (Ouwehand et al., 1999; Zubillaga et al., 2001;
Holzapfel & Schilling 2002)
The probiotic microorganisms should not be pathogenic, have no connection with 
diarrhoeagenic bacteria and no ability to transfer antibiotic resistance genes, as well as be 
able to maintain genetic stability. To be recognized as functional food components, they 
should demonstrate the following properties: acid- and bile-stability, resistance to digestive 
enzymes, adhesion to intestine surface, antagonistic activity against human pathogens, anti-
carcinogenic and anti-mutagenic activity, cholesterol-lowering effects, stimulation of the 
immune system without inflammatory effects, enhancement of bowel motility, maintenance 
of mucosal integrity, improvement of bioavailability of food compounds and production of 
vitamins and enzymes. (Ouwehand et al., 1999) The technological properties of bacteria 
play a very significant role in the production of probiotics. (Saarela et al., 2000)
They possess good sensorial properties, fermentative activity, good survival during 
freeze-drying or spray-drying, proper growth and viability in food products, phage resistance 
and high stability during long-term storage. The majority of bacteria belonging to the 
Lactobacillus and Bifidobacterium genera are recognized as safety. It is generally accepted 
that, with the only exception of streptococci and enterococci, lactic acid bacteria are rarely 
pathogenic to humans and animals. They have been used in production of foods since ancient 
times with no negative effects on humans. However, the list of probiotic strains is rather 
short. It includes strains offered by the dairy industry and some scientific groups.
(Ouwehand et al., 1999; Holzapfel & Schillinger 2002)
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MECHANISM OF PROBIOTICS
Probiotic microorganisms are considered to support the host health. However, the 
support mechanisms have not been explained. (Holzapfel et al., 1998) There are studies on 
how probiotics work. So, many mechanisms from these studies are trying to explain how 
probiotics could protect the host from the intestinal disorders. These mechanisms listed below 
briefly. (Rolfe 2000, Çakır 2003, Salminen et al., 1999, Castagliuola et al., 1999)
1. Production of inhibitory substances: Production of some organic acids, hydrogen peroxide 
and bacteriocins which are inhibitory to both gram-positive and gram-negative bacteria.
2. Blocking of adhesion sites: Probiotics and pathogenic bacteria are in a competition. 
Probiotics inhibit the pathogens by adhering to the intestinal epithelial surfaces by blocking 
the adhesion sites.
3. Competition for nutrients: Despite of the lack of studies in vivo, probiotics inhibit the 
pathogens by consuming the nutrients which pathogens need.
4. Stimulating of immunity: Stimulation of specific and nonspecific immunity may be one 
possible mechanism of probiotics to protect the host from intestinal disease. This mechanism 
is not well documented, but it is thought that specific cell wall components or cell layers may 
act as adjuvants and increase humoral immune response.
5. Degradation of toxin receptor: Because of the degredation of toxin receptor on the 
intestinal mucosa, it was shown that S. boulardii protects the host against C.difficile intestinal 
disease.
Some other offered mechanisms are suppression of toxin production, reduction of gut pH, 
attenuation of virulence. (Fooks et al., 1999)
PREBIOTICS
Prebiotics are an alternative for probiotics or their cofactors. They are defined as non-
digestible or low-digestible food ingredients that benefit the host organism by selectively 
stimulating the growth or activity of one or a limited number of probiotic bacteria in the 
colon. (Crittenden & Playne 1996; Dimer & Gibson 1998; Zimmer & Gibson 1998; 
Manning & Gibson 2004)
Prebiotic oligosaccharides can be produced in three different ways: by extraction from 
plant materials, microbiological synthesis or enzymatic synthesis, and enzymatic hydrolysis 
of polysaccharides. (Crittenden & Playne 1996; Gulewicz et al., 2003) The majority of 
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prebiotic oligosaccharides are produced on the industrial scale and are widely available on 
the market Recently, many patents concerning probiotic oligosaccharides have been claimed 
and this field is continuously increasing. (Crittenden & Playne 1996)
Free radicals are a major cause of many degenerative diseases, such as 
atherosclerosis, cancer, cardiovascular diseases, inflammatory bowel diseases, skin aging, old 
age dementia diseases. (Shklar 1998; Surh 1999; Kris-Etherton et al., 2002; Ferrari & 
Torres 2003)
Epidemiological data and randomized clinical trials provide ample indications that 
antioxidants play a fundamental role in the prevention of cancer and cardiovascular reactive
oxygen species and metal chelators that protect human cells and reduce oxidative damages.
The Russian scientist and Nobel laureate Eli Metchnikoff first introduced the positive 
role of certain bacteria to the human body. In the beginning of the 20th century he suggested 
that it would be possible to replace harmful microbes with useful ones. At that time he was a 
professor at the Pasteur Institute in Paris (Metchnikoff E. 1907) He believed that the aging 
process was due to toxins such as phenols, indols and ammonia in the large intestine, 
produced by proteolytic microbes such as clostridia. Clostridia are normal to the gut. He 
noted that milk fermented with lactic acid bacteria inhibited the growth of the proteolytic 
bacteria because of the low pH produced by the fermentation of the lactose. Metchnikoff also 
observed that certain rural peoples in Europe such as in Bulgaria, who lived mainly on milk 
fermented with lactic acid bacteria, lived a relatively long life. He then introduced sour milk 
fermented with the bacteria to his diet and found his health benefited from the consumption. 
He called it “Bulgarian Bacillus”.
The first person to isolate Bifidobacterium was Henry Tissier. He also was from the 
Pasteur Institute. He isolated the bacterium from a breast-fed infant and called it Bacillus 
bifidus communis. It was later renamed Bifidobacterium bifidum. Tissier concluded it was 
the predominate microflora in breast-fed infants and recommended it for babies suffering 
from diarrhea. (Tissier H. 1900)  
In 1917, the German professor Alfred Nissle isolated the bacterium Escherichia coli
from the faeces of a World War I soldier who didn’t develop enterocolitis when he had a 
severe case of shigellosis. He used the strain to treat intestinal diseases such as shigellosis and 
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salmonellosis with a considerable amount of success. At that time antibiotics weren’t yet 
discovered. The probiotic Escherichia coli are still in use today. It’s been shown to directly 
interact with the adaptive immune system. (Kruis W. 2004-Nissle 1917)
MEDIA FOR ISOLATION
Often abbreviated to MRS, this type of bacterial growth medium is so-named by its 
inventors: de Man, Rogosa and Sharpe. Developed in 1960, this medium was designed to 
favour the luxuriant growth of Lactobacilli for lab study. It contains sodium acetate, which 
suppresses the growth of many competing bacteria (although some other Lactobacillales, like 
Leuconostoc and Pediococcus, may grow). This medium has a clear brown colour. (EMD 
Chemicals, MRS Agar 2002)
MRS agar typically contains (w/v):
 1.0 % peptone
 0.8 % meat extract 
 0.4 % yeast extract
 2.0 % glucose
 0.5 % sodium acetate trihydrate 
 0.1 % polysorbate 80 (also known as Tween 80) 
 0.2 % dipotassium hydrogen phosphate
 0.2 % triammonium citrate
 0.02 % magnesium sulfate heptahydrate 
 0.005 % manganese sulfate tetrahydrate 
 1.0 % agar
 pH adjusted to 6.2 at 25°C 
The yeast and meat extracts and peptone provide sources of carbon, nitrogen and vitamins
for general bacterial growth. The yeast extract also contains vitamins and amino acids
specifically required by Lactobacilli. polysorbate 80 is a surfactant which assists in nutrient 
uptake by Lactobacilli. Magnesium sulfate and manganese sulfate provide cations used in 
metabolism. (de Man et al., 1960)
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ISOLATION
At the start of the 20th century, probiotics were thought to beneficially affect the host 
by improving its intestinal microbial balance, thus inhibiting pathogens and toxin producing 
bacteria. (Metchnikoff E. 1907) Today, specific health effects are being investigated and 
documented including alleviation of chronic intestinal inflammatory diseases (Mach. T. 
2006), prevention and treatment of pathogen-induced diarrhoea urogenital infections (Yan F, 
Polk DB. 2006), and atopic diseases. (Vanderhoof JA 2008)
Lactic acid bacteria (LAB) are Gram-positive, non--spore forming, catalase-negative 
bacteria that are devoid of cytochromes and are of nonaerobic habit but are aero-tolerant, 
fastidious, acid tolerant and strictly fermentative; lactic acid is the major end-product of sugar 
fermentation. They are the most widely used bacteria as starter cultures for the industrial 
processing of fermented dairy, meat, vegetable and cereal products. Reduction of PH and 
conversion of sugars to organic acids are the primary preserving actions that these bacteria 
provide to fermented food. (L.T. Axelsson 1989)
The isolated bacteria were identified as Lactobacillus spp. by observing their 
morphological characteristics and by means Gram staining, motility test, catalase test, 
endospore test, milk coagulation activities. (M.Z. Hoque et al., 2010)
Lactobacilli are an extremely important group of probiotic bacteria inhibit undesirable 
microflora in the gut and create a healthy equilibrium between beneficial and potentially 
intestinal pathogens. The study was attempted to isolate Lactobacilli strains from goat milk to 
search for a new effective antibacterial probiotic strains. From 40 raw goat milk samples, 48 
Lactobacilli isolates were isolated, identified and analyzed for their probiotic properties 
including acid and bile salt tolerance, antibacterial activity against enteric pathogens, 
antibiotic resistance patterns and production of bacteriocin. Out of these Lactobacillus
species, five isolates were potential probiotics, and bacteriocins produced by them showed 
demonstrable antibacterial activity against the test pathogens such as S. typhi, Pr. vulgaris, K. 
pneumoniae, Sh. flexneri, E. aerogenes and E. coli. The bacteriocin produced by L. 
plantarum (G95a) and L. rhamnosus (G119b) was prominent antibacterial, resistant to heat at 
1210C and tolerated acidic pH 3 but sensitive to pH 9. The present study suggested that 
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isolated Lactobacillus strains have an excellent probiotic potential and control of enteric 
infections and restoration of microbial gut flora. (D.H. Tambekar and S.A. Bhutada 2010)
BIOCHEMICAL CHARACTERIZATION
Biochemical characterization is primary aspect of identification of the culture or the isolates 
obtained.
Catalase is a common enzyme found in nearly all living organisms that are exposed to 
oxygen, where it functions to catalyze the decomposition of hydrogen peroxide to water and 
oxygen. (Chelikani P. et al., 2004)
Hydrogen peroxide is a harmful by-product of many normal metabolic processes: to 
prevent damage, it must be quickly converted into other, less dangerous substances. To this 
end, catalase is frequently used by cells to rapidly catalyze the decomposition of hydrogen 
peroxide into less reactive gaseous oxygen and water molecules. Probiotics isolates as per the 
Bergey’s manual catalase negative, which is the significant character of probiotics. (Gaetani 
G. et al., 1996)
The indole test is a biochemical test performed on bacterial species to determine the 
ability of the organism to split indole from the amino acid tryptophan. This division is 
performed by a chain of a number of different intracellular enzymes, a system generally 
referred to as "tryptophanase."(Macfaddin 1980) As per the Bergey’s manual indole 
production test is negative of probiotics isolates.
This test is used to determine two things. The MR portion (methyl red) is used to 
determine if glucose can be converted to acidic products like lactate, acetate, and formate. 
The VP portion is used to determine if glucose can be converted to acetoin. As per the 
bergey’s manual MR  test is positive and VP test is negative of probiotics isolates.
Methyl red is an indicator dye that turns red in acidic solutions. It is an azo dye, and is 
a dark red crystalline powder. Methyl red is a pH indicator; it is red in pH under 4.4, yellow 
in pH over 6.2, and orange in between, with a pKa of 5.1 ( H. T. Clarke and W. R. Kirner
1941)
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Tests for the ability of bacteria to convert citrate (an intermediate of the Kreb’s cycle) 
into oxaloacetate (another intermediate of the Kreb’s cycle). In this media, citrate is the only 
carbon source available to the bacteria. If it cannot use citrate then it will not grow. If it can 
use citrate, then the bacteria will grow and the media will turn a bright blue as a result of an 
increase in the pH of the media.  Probiotics isolates were not able to utilize citrate as 
according to bergey’s manual.
Gelatin agar media is used to test if bacteria can digest the protein gelatin. To digest 
gelatin, the bacteria must make an enzyme called gelatinase. Gelatin as a solidifing agent and 
sourse of protein, it is used as gelatine agar to study its utilization as well as for its 
liquification. According to bergey’s manual any species of probiotics are not able to utilize 
gelatin and not able to liquefy it.
In starch hydroltsis, undegraded starch reacts with Iodine to form a dark blue starch-
iodine complex that covers the entire agar. If starch (polysaccharide) is broken down into 
glucose (or any other monosaccharides/ di saccharides), glucose will then react with iodine, 
forming a clear zone surrounding streak line.
As one of the best source of carbohydrate starch is utilized or not can be studied by 
application of iodine.
Casein (a protein) is broken down by protease into peptones and amino acids. During 
the degradation process, polypeptide bonds are broken. Once the bonds are broken, amino 
acids are produced. A clear zone surrounding streak line of agar indicates positive result.
Decomposition of amino acid “cysteine” is detected by the formation of ferrous 
sulphide when Hydrogen Sulphide is release. When H2S is produced, sulphide ion reacts 
with the metal salt to product a black precipitate positive result.
Urease breaks down urea into ammonia (NH3) & carbon dioxide (CO2). Phenol red is 
used as pH indicator, pH indicator changes from yellow to bright pink if NH3 is produced.
Bacteria produce acidic products when they ferment certain carbohydrates. The 
carbohydrate utilization tests are designed to detect the change in pH which would occur if 
fermentation of the given carbohydrate occurred. Acids lower the pH of the medium which 
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will cause the pH indicator (phenol red) to turn yellow. If the bacteria do not ferment the 
carbohydrate then the media remains red. If gas is produced as a by product of fermentation, 
then the Durham tube will have a bubble in it. This is known as Sugar fermentation test.
Litmus milk has several components that can be metabolized: lactose (milk sugar); 
casein (milk protein); and litmus (a pH indicator that is purple to blue at neutral to alkaline 
pH and pink under acid conditions). If lactose is fermented, the solution should turn pink. If 
gas is produced during fermentation, bubble or cracks in the milky medium can be observed
(but this is often difficult to observe).If lactose is not fermented and proteins are instead used 
for energy, the solution will become alkaline and more blue. Casein protein may be digested. 
This will coagulate the milk to form a curd (a solid) (Bergey’s manual).
pH AND BILE SALT TOLERANCE
Bacteria used as probiotic strains are joined in the food system with a journey to the 
lower intestinal tract via the mouth. In this food system, probiotic bacteria should be resistant 
to the enzymes like lysozyme in the oral cavity. Then the journey will be going on in the 
stomach and enter the upper intestinal tract which contain bile. In this stage strains should 
have the ability to resist the digestion processes. It is reported that time at the first entrance to 
release from the stomach takes three hours. Strains need to be resistant to the stressful 
conditions of the stomach (pH 1.5-3.0) and upper intestine which contain bile. (Chou and 
Weimer 1999, Çakır 2003)
To show probiotic sufficiencies, they should reach to the lower intestinal tract and 
maintain themselves over there. Because of desirable point the first criteria is looking for 
probiotic strains is being resistant to acid and bile. Bile acids are synthesized in the liver from 
cholesterol and sent to the gall –bladder and secreted into the duodenum in the conjugated 
form (500-700 ml/day). In the large intestine this acids suffer some chemical modifications 
(deconjugation, dehydroxylation, dehydrogenation and deglucuronidation) due to the 
microbial activity. Conjugated and deconjugated bile acids show antimicrobial activity 
especially on E. coli subspecies, Klebsiella spp., and Enterococcus spp. in vitro. The 
deconjugated acid forms are more effective on gram positive bacteria. (Dunne et al., 1999, 
Çakır 2003)
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Among two of selected bifidobacterium strains, HJ 30 and SI 31, showed higher rates 
of survival. (Chung et al., 1998) In another study a large culture collection of lactic acid 
bacteria of NZDRI was screened to select strains to use as probiotics. For this, over 200 
strains of Lactobacillus and Bifidobacterium were examined according to their ability of 
resistant to bile and acid and four of them selected. Three of them were from dairy origins 
and the last one was from human origin. They were compared with the two commercial 
probiotic strains namely Lactobacillus rhamnosus GG and Lactobacillus acidophilus LA-1. 
The isolated strains were analyzed for a series of pH between 1 and 3 and also for tolerance 
against bile at final concentrations of 0, 0.5 and 1% w/v. They were tolerant for the 
conditions mentioned above. While the general survival patterns are similar, the strain from 
human orgin showed higher tolerance. These strains were identified as Lactobacillus
rhamnosus HN001, Lactobacillus rhamnosus HN067, Lactobacillus acidophilus HN017 and 
Bifidobacterium lactis HN019. (Prasad et al., 1998)
In another research, twenty nine Lactobacillus strains of dairy origin were tested  in 
vitro for their probiotic potential. The resistance of bacteria was examined in pH 1 between 
pH 3. Tolerance to bile salt was tested against to 0.3% oxgall. All of the examined strains 
were resistant to pH 3 during 3h, but most of them lost their viability in 1h in pH 1. Also all 
of them were tolerated 0.3% bile salts concentration in 4 h. For in vivo testing the most 
suitable strains were chosen, L.casei Shirota ACA-DC 6002, L.plantarum ACA-DC 146, 
L.paracasei subsp. tolerans ACA-DC 4037. (Maragkoudakis et al. 2005) Also an 
experiment was performed on three Lactobacillus species isolated from human milk whether 
they may use potential probiotic strains.
They were identified as Lactobacillus gasseri and one of them Lactobacillus
fermentum. Survival in low pH and in gastrointestinal environment was examined for a 
comparison with commercial probiotic strains, L.rhamnosus GG, L. casei imunitass and L. 
johnsanii La1. The strains especially L.gasseri showed that it can be used as a potential 
probiotic strain. (Martín et al. 2004)
Bile is a yellow-green aqueous solution whose major constituents include bile acids, 
cholesterol, phospholipids, and the pigment biliverdin . It is synthesized in the pericentral 
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hepatocytes of the liver, stored and concentrated in the gallbladder interdigestively, and 
released into the duodenum after food intake. Bile functions as a biological detergent that 
emulsifies and solubilizes lipids, thereby playing an essential role in fat digestion. This 
detergent property of bile also confers potent antimicrobial activity, primarily through the 
dissolution of bacterial membranes. (M. Begley 2009, C. G. M. Gahan and C. Hill 2005)
Bile Salt Hydrolase activity has been detected in Lactobacillus, Bifidobacterium  
Enterococcus Clostridium , and Bacteroides  spp. Lactobacilli and bifidobacteria are routinely 
used as probiotic strains, while Bacteroides, Clostridium, and Enterococcus spp. are also 
commensal inhabitants of the gastrointestinal tract. To date, BSH activity has not been 
detected in bacteria isolated from environments from which bile salts are absent (e.g., 
Lactococcus lactis or Streptococcus thermophilus). With the exception of two strains of 
Bacteroides, all other BSH-positive bacteria are gram positive. All other gram-negative 
intestinal bacteria that have been examined (including Escherichia coli and Salmonella 
enterica serovar Typhimurium) neither demonstrate BSH activity nor possess bsh homologs 
in their genome. (Holzapfel W. H. and P. Haberer 1998)
bsh mutant pairs provide a link between bile salt hydrolysis and bile tolerance. A 
Lactobacillus amylovorus mutant with a partial decrease in BSH activity isolated using an N-
methyl-N 1-nitro-N-nitrosoguanidine mutagenesis strategy displayed decreased growth rates in 
the presence of bile salts. (J. M. Antoine and F. Schneider 2000) Also, mutation of bsh in L. 
plantarum and L. monocytogenes renders cells significantly more sensitive to bile and bile 
salts.. However, it has been proposed that since the protonated (nondissociated) form of bile 
salts may exhibit toxicity through intracellular acidification in a manner similar to organic 
acids, BSH-positive cells may protect themselves through the formation of the weaker 
unconjugated counterparts (Leer R. J. et al., 1993)
Bile salts usually only have slight affects (if any) on bacterial cells at every pH 
examined, glycoconjugated bile salts are extremely toxic at acidic pH and bsh mutants are 
significantly more inhibited than corresponding parent cells. (C. G. M. Gahan, and C. Hill.
2005) Thus, BSHs are particularly important in combating the toxic effects of 
glycoconjugated bile salts at low pH, and BSH activity may be of particular importance at the 
point where bile enters the duodenum and where acid reflux may occur from the stomach, or 
in localized microenvironments in the intestine when the pH is lowered dsby lactic acid 
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bacteria. The fact that BSHs have been shown to preferentially hydrolyze glycoconjugated 
bile salts , together with the observation that BSHs have slightly acidic pH optima (usually
between pH 5 and 6)  may serve to substantiate this theory. (Tuohy K. M., et al., 2003)
Probiotics potential of LAB is necessarily its ability to resist bile salts and acidic pH.
(Lee and Salminen 1995) In this study, three isolated excellent probiotic, commercial 
probiotic and standard probiotic bacterial strains showed acid tolerance at pH 2 and bile salt 
tolerance at 2%. Before reaching the intestinal tract, probiotic bacteria must first survive 
transit through the stomach where the pH can be as low as 1.5 to 2. (Dunne et al., 2001)
Tolerance to bile salts is a prerequisite for colonization and metabolic activity of bacteria in 
the small intestine of the host. (Havenaar et al., 1992) This will help Lactobacilli to reach 
the small intestine and colon and contribute in balancing the intestinal microflora.
(Tambekar and Bhutada 2010)
Method was used to determine bile tolerance of selected LAB. Before testing for bile 
tolerance, LAB strains were grown at 37oC for 24 hour in MRS broth without bile. One ml of 
the culturebroth was poured onto MRS agar with bile salt concentrations of 2000, 3000 and 
4000 ppm. Bacterial growth was determined after incubation at 37oC for 48 hour. The 
modified method of (Erkkila and Petaja 2000) was applied in the study.
Bile salt tolerance of the Lactobacillus strains was able to grow in MRS agar 
supplemented with3000 ppm bile salt. In the human GI-tract, the mean bile salt concentration 
is believed to be 3000 ppm, which is considered as critical and high enough to screen for 
resistant strains. (Gilliland et al., 1977; Goldin and Gorbach 1992)
However, L. rhamnosus strains isolated from Parmigiano Reggiano cheese were able 
to survive at bile salt concentration of 10,000, 15,000 and 20,000 ppm after 48 hour of 
incubation at 37oC. (Succi et al., 2005) It has been reported that certain strains of 
Lactobacillus are able to reduce this detergent effect by their ability to hydrolyze bile salt by 
bile salt hydrolase enzyme (BSH). (Erkkila and Petaja 2000)
NaCl TOLERANCE
NaCl is an inhibitory substance when applied in high amountand thus may inhibit 
growth of certain types of bacteria. Lactobacillus spp. isolated from yoghurt. Yoghurt 
samples were collected from Grameen Dannone yoghurt, Bogra and Khulna Districts of 
Review of Literature
25
Bangladesh. The isolated lactobacilli from yoghurts were able to tolerate 1-9% NaCl. NaCl is 
an inhibitory substance which may inhibit growth of certain types of bacteria. The current 
result respectively showed that Lactobacillus spp. isolated from yoghurts On the other hand, 
they were able to survive and were able to tolerate 1-9% of NaCl and good growth was had 
partial multiplication abilities at pH 6.60. In per ml observed at 1% NaCl. (M.Z. Hoque et 
al., 2010)
ANTIBIOTIC SUSCEPTIBILITY
Routine antibiotic susceptibility testing of lactic acid bacteria (LAB) and 
bifidobacteria may be advisable in a number of instances e.g. for checking the biosafety of 
potentially probiotic isolates. In fact, there is concern over the possible spread of antibiotic 
resistance determinants from bacteria used in probiotic products. However, there is still a lack 
of agreement on the MIC interpretative breakpoints mainly for Lactobacillus spp.
Bifidobacteria are common inhabitants in the human and animal intestines, and are 
generally associated with good intestinal health. They are increasingly used as probiotics and 
one target for their probiotic use is attenuation of ecological disturbances in the microbiota 
caused by antibiotic therapy. Bifidobacteria are typically susceptible to majority of clinically 
relevant antibiotics such as penicillins, cephalosporins and macrolides, and bifidobacterial 
population is therefore vulnerable to changes during antibiotic administration. However, their 
susceptibility to tetracycline is variable. (Moubareck et al., 2005, Delgado et al., 2005)
Tetracycline group antibiotics are widely used for therapeutics and prophylaxis of 
clinical infections in humans and animals and in some countries they are additionally used as 
growth promoters in animals. Tetracycline resistance is increasingly common in bacteria 
living in a variety of ecological niches and several transferable determinants have been linked 
to the resistance. (Roberts, 1979) Ribosomal protection protein type resistance genes, 
especially tet (W), have been detected in several Bifidobacterium species. (Moubareck et al.,
2005, Aires, 2007) However, the data on the species distribution of bifidobacterial
population and changes in antibiotic susceptibility patterns caused by tetracycline 
administration is scarce.
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GROWTH CURVE
The first stage of the researches is represented by the determination, under laboratory 
conditions, of the evolution of Lactobacillus plantarum BS1 andBS3 strains in the case of 
using MRS medium. From the data presented it results that the two strains have a similar 
profile of the growth curve. The lag phase is very short and the exponential growth phase 
lasts for approximately 20 hours. The duplication time is shorter for Lactobacillus plantarum 
BS1 Instead, for Lactobacillus plantarum BS3 strain it results a greater productivity The 
differences between the two strains can be attributed to the calculation and determination
differences of the parameters considered. ( E. Vamanu. et al., 2011)
ANTIMICROBIAL ACTIVITY
Antimicrobial activity is one of the most important selection criteria for probiotics. 
Antimicrobial activity targets the enteric undesirables and pathogens. (Klaenhammer Kullen 
1999) Antimicrobial effects of lactic acid bacteria are formed by producing some substances 
such as organic acids (lactic, acetic, propionic acids), carbon dioxide, hydrogen peroxide, 
diacetyl, low molecular weight antimicrobial substances and bacteriocins. (Quwehand and 
Vesterlund 2004, Çakır 2003) Till today there are some researches on showing that different 
species produce different antimicrobial substances. Here are some examples of these 
substances: Lactobacillus reuterii, which is a member of normal microflora of human and 
many other animals, produce a low molecular weight antimicrobial substance reuterin; 
subspecies of Lactococcus lactis produce a class I bacteriocin, nisin A; Enterococcus feacalis 
DS16 produces a class I bacteriocin cytolysin; Lactobacillus plantarum produces a class II
bacteriocin plantaricin S; Lactobacillus acidophilus produces a class III bacteriocin
acidophilucin A. (Quwehand and Vesterlund 2004) Production of bacteriocins is highly
affected by the factors of the species of microorganisms, ingredients and pH of medium,
incubation temperature and time. Nisin, produced by L. lactis subsp. lactis is the wellknown 
bacteriocin and it is allowed to use in food preparations. (Çakır 2003)
Lactobacilli and Bifidobacteria isolated from human ileum were assayed if they have 
antimicrobial activity against a range of indicator microorganisms, Listeria, Bacillus, 
Enterococcus, Staphylococcus, Clostridium, Pseudomonas, E. coli, Lactobacillus, 
Streptococcus, Bifidobacterium and Lactococcus. Antimicrobial activity of Lactobacillus 
salivarus UCC118 was counted against to these bacteria listed above. The study showed that 
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Lactobacillus salivarus UCC118 is significantly capable of inhibiting in vitro growth of both 
some gram positive and some gram negative bacteria such as, L. fermentum KLD, B. longum, 
B. bifidum, Bacillus subtilus, B. Cereus, B.thuringiensis, E. faecalis, E. faecium etc. although 
it is not effective against some of Lactobacillus, Lactococcus, Leuconostoc, Streptococcus 
etc. species. (Dunne et al., 1999)
Some milk products were used to isolate potential probiotic bacteria and
determination of their possible antimicrobial activities. Staphylococcus aureus, Escherichia 
coli, Pseudomonas aeruginosa, Salmonella typhi, Serratia marcescens and Candida albicans 
were used as indicator microorganisms. After the study, the results showed that, Yakult and 
Ski D’ Lite probiotics inhibited all of the test indicator microorganisms, Nestle yogurt 
probiotics were bactericidal for S.aureus and P.aeruginosa but inhibitory for S. typhi , Neslac 
probiotics killed E. coli and S. typhi while they were only inhibitory for S.aureus and C. 
albicans, Gain probiotics inhibited C. albicans. (Chuayana et al., 2003)
In another study eight lactic acid bacteria strains producing bacteriocins were isolated 
from Burkina Faso fermented milk and they were examined for the antimicrobial activity 
against Enterococcus faecalis 103907 CIP, Bacillus cereus 13569 LMG, Staphylococcus 
aureus ATCC 25293, Escherichia coli 105182 CIP. The lactic acid bacteria strains were 
identified as Lactobacillus fermentum, Pediococcus spp., Lactococcus spp., Leuconostoc 
mesenteroides subsp. mesenteroides. The diameters of inhibition zones were obtained 
between 8 mm and 12 mm. Lactobacillus fermentum (S1) gave the biggest zone around 12 
mm on Enterococcus faecalis while the smallest one is obtained from Leuconostoc 
mesenteroides subsp. mesenteroides (S5) on the same strain Enterococcus faecalis.
(Savadogo et al., 2004)
In a research which was aimed to test the production of bacteriocin in vaginal
lactobacilli flora and characterization of this flora was also made. First antimicrobial activity 
was assayed for 100 vaginal lactobacilli isolates. Six of them were determined for the 
production of bacteriocin. In this study, common human pathogens Gardneralla vaginalis, 
Pseudomonos aeroginosa, Proteus vulgaris, Escherichia coli, Enterobacter cloacae, 
Streptococcus milleri, Staphylococcus aureus and Candida albicans were used as indicator 
microorganisms. Six of the strains had bacteriocin activity against eight of ten different 
Lactobacillus species an also S.milleri, P. vulgaris, P. aeroginosa, E. coli, E. cloacae and G. 
vaginalis. But none of isolated strains showed efficiency on test organisms S. aureus and C. 
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albicans. Also some characteristics of bacteriocins were obtained from the research.
(Karaoğlu et al., 2003)
In another research, potential probiotic lactobacilli strains (L.reuteri, L. plantarum, 
L.mucosae, L. rossiae strains) (from pig feces), used as additives in pelleted feeding, were 
examined according to their antibacterial activity against to Salmonella typhimurium ATCC 
27164, E. coli, C. perfringens 22G, S. aureus ATCC 25923, B. megaterium F6, L. innocua 
DSM 20649 and B. hyodysenteriae ATCC 27164. Generally the cell free extracts of 
lactobacilli were able to inhibit all potential pathogens except B. hyodysenteriae ATCC 
27164. The study showed that, neutralization and treatment with catalase affect the 
antibacterial activity a little  A similar study was conducted and in that study four 
Lactobacillus strains (L. salivarus CECT5713, L. gasseri CECT5714, L.gasseri CECT 5715 
and L.fermentum CECT5716) isolated from human milk were investigated whether they have 
antimicrobial potential and for comparison L. coryniformis CECT5711 was used. All of the 
strains showed antibacterial properties against pathogenic bacteria (Salmonella choleraesuis
CECT4155, CECT409 and CECT443, Esherichia coli CECT439 and E. coli O157:H7
serover CECT4076, Staphylococcus aureus CECT4013 and CECT9776, Listeria
monocytogenes Scott A and the spoilage strain Clostridium tyrobutyricum 
CECT4011).However, the antimicrobial properties of lactobacilli strains varied and L. 
Salivarus CECT5713 revealed not only the best in vitro antibacterial activity, but also the 
highest protective effect against a Salmonella strain in the murine infection model. (Olivares
et al., 2005)
Antimicrobial activity is thought to be an important means for Probiotics to 
competitively exclude or inhibit invading bacteria. (Carr et al., 2002 ; Roos and Holm
2002) Some do so by secreting non-specific antimicrobial substances, such as short-chain 
fatty acids (Carr et al., 2002) or hydrogen peroxide (Eschenbach et al., 1989), while others 
produce toxins with very narrow killing ranges, such as bacteriocins, bacteriocin-like 
inhibitory substances (BLIS), and bacteriophages. (Smith et al., 2007; Tagg and Dierksen
2003) Production of antimicrobial substances against pathogens has been proposed as one of 
the mechanisms by which they improve health. These substances include bacteriocins and 
organic acids, which inhibit a range of common and emerging food borne pathogens. 
(Opeyemi Daniel Amund, 2010)
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       Previous investigations have shown that certain strains of Lactobacillus species act as 
probiotic organisms within the gastrointestinal tract, helping to reduce colonization and 
infection with potential enteric pathogenic bacteria. Two potentially debilitating enteric 
pathogens, Entertoxigenic Escherichia coli and Enterohemorrhagic Escherichia coli, affect 
millions of people worldwide; however data on the effectiveness of probiotics for these 
strains of E. coli are minimal. In this study, we investigated the inhibitory effect of four 
Lactobacillus species against the growth of these two pathogenic strains of E. coli. The 
amount of growth inhibition was determined using both live lactobacilli cultures and 
supernatant obtained from actively growing lactobacilli broth cultures. The amount of growth 
inhibition of each E. coli strain varied depending on the method as well as the species of 
Lactobacillus used. Experimental findings suggest that Entertoxigenic E. coli was strongly 
inhibited when exposed to live lactobacilli cells, but only partially inhibited when exposed to 
supernatant alone. In contrast, Enterohemorrhagic E. coli was equally inhibited by exposure
to live cells or supernatant. (Apella et al., 1990)
             Urinary tract infection (UTI) is the most common bacterial infection seen in clinical 
practice. Human UTI comprises disease entities such as acute pyelonephritis with renal 
parenchymal involvement, cystitis limited to the urinary bladder, and asymptomauria. (W. E.
McKevitt M., 1985) Enterobacteriaceae such as Escherichia coli, which are normal 
inhabitants of human intestines, account for the vast majority of these uncomplicated 
infections. (Genital areas are therefore recommended for prevention of UTI. On the other 
hand, studies have shown a correlation between a loss or disruption of the normal genital 
microflora, in particular Lactobacillus species, and an increased incidence of genital and 
bladder infections. (Redondo-Lopez et al., 1990) Emerging role of lactobacilli in the control 
and maintenance of the vaginal bacterial micro flora. Preclinical and clinical reports have 
focused on lactobacillus strains, their possible prophylactic effects against experimental E. 
coli infection, and the use of these strains for the prevention of human urogenital infections.
           Suitable animal experimental models are required for appropriate preclinical studies of 
UTIs. Hagberg et al. were the first to show that mice could be challenged intravesically (by 
introducing pathogens directly into the bladder) without further manipulations of the urinary 
tract (Hagberg L. et al., 1983) and the murine model of ascending pyelonephritis has served 
as an excellent tool for defining the roles of individual virulence factors in the pathogenesis 
of UTI. (Hopkins W. J. et al., 1998)
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Time course and host responses to Escherichia coli urinary tract infection in 
genetically distinct mouse strains.  It should be noted, however, that the inoculums doses 
used in murine models are very high (108 CFU). Furthermore, high bladder infection levels 
reportedly persisted over the 14-day study period only in C3H/HeJ and C3H/OuJ mice, which 
are lipopolysaccharide (LPS) nonresponder strains, while strains such as C3H/HeN, 
C57BL/6, BALB/c, DBA.1, DBA.2, and AKR showed progressive resolution of bladder 
infections over a 14-day period. (Hopkins W. J. et al., 1998)
Intraurethral treatment with L. casei Shirota (108 CFU/day) inhibited pathogen growth 
in the urinary tract and suppressed infection-induced inflammatory responses. The 
characteristics of this antimicrobial activity included (i) a heat-killed (HK) preparation of L. 
casei Shirota effectively lowering levels of infectious bacteria and (ii) effectiveness of 
treatment during the post infection period. These results suggest that the probiotic L. casei
strain Shirota is potentially useful for both preventive and therapeutic treatment of UTI. This 
review considers whether probiotics are effective agents for the treatment and/or prevention 
of bacterial vaginosis (BV). There seems to be an association between the absence of, or low 
concentrations of, vaginal lactobacilli and the development of BV. Many studies have 
suggested that the presence of H2O2-producing vaginal lactobacilli may protect against BV, 
although some studies do not support this hypothesis. In-vitro studies have suggested that 
certain specific strains of lactobacilli are able to inhibit the adherence of Gardnerella 
vaginalis to the vaginal epithelium and/or produce H2O2, lactic acid and/or bacteriocins, 
which inhibit the growth of bacteria causing BV. concerning the effectiveness of the 
administration of lactobacilli for the treatment of BV are mostly positive, it cannot yet be 
concluded definitively that probiotics are useful for this purpose.( Falagas M.E. et al., 2007)
                   A strain of Lactobacillus, identified as Lactobacillus fermentum L23, was 
selected from among 100 strains isolated from vaginal swabs of healthy, non-pregnant, pre-
menopausal women. L. fermentum L23 was chosen on the basis of its bacteriocinogenic 
ability and its properties relevant to colonization, i.e. self-aggregation, adherence to vaginal 
epithelial cells and co-aggregation with bacterial pathogens. The antimicrobial preventative 
and curative effects produced by the probiotic L. fermentum L23 administered locally against 
Escherichia coli in a murine vaginal tract infection model were studied. Treatment with L. 
fermentum L23 during the post-infection period showed complete inhibition of pathogen 
growth from day 5. Thus, this in vivo study indicated that the probiotic bacterium L. 
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fermentum L23 produced both preventative and curative effects on E. coli growth. The 
beneficial properties and the production of antimicrobial metabolites may act in situ to inhibit 
a pathogenic micro-organism within the vaginal environment. Strain L23 could be a good 
natural alternative to other therapies used for genital infections. (Pascual L. et al., 2010)
Lactic acid bacteria (LAB) are generally regarded as safe and their antimicrobial 
peptides (bacteriocins) have been used in the preservation of many food products. Various 
claims have been attributed to LAB with probiotic properties, e.g. reduction or prevention of 
gastrointestinal disorders, including inflammatory bowel disease, alleviation of lactose 
intolerance, lowering of serum cholesterol levels, and stimulation of the immune system and 
control of tumour growth. Some probiotic claims may be associated with the production of 
antimicrobial peptides (bacteriocins).
The inhibitory mechanism was found to be dependent on the lowering of the pH of 
the medium and production of lactic acid. The antibacterial activity of L. paracasei 17 and L. 
casei 299 from NCDC were more effective in inhibiting Salmonella enteritidis, within 8hrs 
contact of fermented whey. Among various species, Lactobacillus acidophilus (Gandhi and 
Nambudripad 1978), L. rhamnosus (Isolauri et al., 1995), L. casei, have been shown their 
efficacy in prophylactic management of acute diarrhoea in children, with an associated 
increase in the immunity.
Several studies have been carried out to investigate the types of antimicrobials 
produced by probiotics and the range of pathogens susceptible to them. Common 
antimicrobials produced include bacteriocins (antimicrobial proteinaceous substances, e.g. 
nisin), hydrogen peroxide and organic acids such as lactic and acetic acids. In vitro and in 
vivo studies by Wang et al. (2004) showed suppression of the pathogen Helicobacter pylori
by Lactobacillus acidophilus LA5 and Bifidobacterium lactis BB12 contained in yoghurt.
(Opeyemi Daniel Amund 2010)
Spent culture supernatant (SCS) of the probiotic Lactobacillus rhamnosus GG had 
been reported to exert antibacterial activity against Salmonella typhimurium. However, the 
chemical identity of the antimicrobial compound(s) responsible remained unknown. A survey 
of the antimicrobial compounds produced by L. rhamnosus GG was performed. Lactobacillus 
rhamnosus GG produced a low-molecular weight, heat-stable, non-proteinaceous bactericidal 
substance, active at acidic pH against a wide range of bacterial species. (Sigrid C.J.et al.,
2006) Antimicrobial substances produced by lactic acid bacteria can be divided into two main 
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groups: low molecular mass substances with molecular mass <1000 Da and high molecular 
mass substances with molecular mass >1000 Da, such as bacteriocins. All non-bacteriocin 
antimicrobial substances from LAB are of low molecular mass. (J.W. Collins et al., 2010)
BACTERIOCIN OR ANTIMICROBIAL PROTEIN PURIFICATION
Bacteriocins were first identified almost 100 years ago as a heat-labile product present 
in cultures of Escherichia coli V and toxic to E. coli S and were given the name of colicin to 
identify the producing species. (Gratia 1925) Fredericq demonstrated that colicins were 
proteins and that they had a limited range of activity due to the presence or absence of 
specific receptors on the surface of sensitive cells. (Fredericq 1946) Since then, bacteriocins 
have been found in all major lineages of Bacteria and, more recently, have been described as 
universally produced by some members of the Archaea. (Riley and Wertz 2002a; Riley and 
Wertz 2002b; Shand and Leyva 2008) According to Klaenhammer, 99% of all bacteria may 
make at least one bacteriocin, and the only reason we have not isolated more is that few 
researchers have looked for them. (Klaenhammer 1999)
Two main features distinguish the majority of bacteriocins from classical antibiotics: 
bacteriocins are ribosomally synthesized and have a relatively narrow killing spectrum. The 
bacteriocin family includes a diversity of proteins in terms of size, microbial target, mode of 
action, release, and immunity mechanisms and can be divided into two main groups: those 
produced by Gram-negative and Gram-positive bacteria. (Gordon et al., 2006; Heng et al., 
2007)
Bacteriocins of Gram-negative bacteria
Surveys of E. coli, Salmonella enterica, Hafnia alvei, Citrobacter freundii, Klebsiella 
oxytoca, Klebsiella pneumoniae, and Enterobacter cloacae reveal levels of bacteriocin 
production ranging from 3 to 26% of environmental isolates. (Gordon et al., 2006; Riley et 
al., 2003) Colicins, bacteriocins produced by E. coli, are found in 30–50% of the strains 
isolated from human hosts and are often referred to as virulence factors. (Riley and Gordon 
1992) Much higher levels of bacteriocin production have been found in some Gram-negative 
bacteria, such as Pseudomonas aeruginosa, in which >90% of both environmental and 
clinical isolates produce bacteriocins. (Michel-Briand and Baysse 2002)
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Since their discovery, the colicins of E. coli have been the most extensively studied 
Gram-negative bacteriocins, and they now serve as a model system for investigating the 
mechanisms of bacteriocin structure/function, genetic organization, ecology, and evolution. 
(Cascales et al., 2007) Colicins are high molecular weight proteins that kill target cells 
through a variety of mechanisms. Nomura showed that colicins E1 and K inhibit 
macromolecular synthesis without arrest of respiration, colicin E2 causes DNA breakdown, 
and colicin E3 stops protein synthesis. (Nomura 1967) In each case, he showed that the 
lethal action is reversed by treatment with trypsin. Since his pioneering work, colicins were 
shown to kill their targets by either membrane permeabilization or nucleic acid degradation. 
(Braun et al., 1994; Riley and Wertz 2002b; Smarda and Smajs 1998)
Colicins are usually encoded on one of two types of colicinogenic plasmids. (Pugsley 
and Oudega 1987) Type A plasmids are small (6 to 10 kb) and present in numerous copies 
per cell. They are mobilizable in the presence of a conjugative plasmid and are amplifiable. 
Type B are monocopy plasmids of about 40 kb, which carry numerous genes in addition to 
those encoding colicin activity and are able to conjugate. However, plasmid carriage of 
bacteriocins is not a requirement. A close relative to the colicins, the bacteriocins of Serratia 
marcesens, are found on both plasmids and the chromosome. (Ferrer et al., 1996; Guasch et 
al., 1995) A colicin protein is comprised of three functionally distinct domains; receptor 
recognition, protein translocation, and killing. (Cao and Klebba 2002) In colicins, the central 
domain comprises about 50% of the protein and is involved in the recognition of specific cell 
surface receptors on the outer membrane of the target cell. (Zakharov and Cramer 2004)
In addition to colicins, E. coli strains produce a second type of bacteriocin, known as 
microcins, which are smaller than colicins and share more properties with the bacteriocins 
produced by Gram-positive bacteria, including thermostability, resistance to some proteases, 
relative hydrophobicity, and resistance to extreme pH. (Baquero and Moreno 1984; Gillor 
et al., 2004; Pons et al., 2002) Fourteen microcins have been reported to date, of which only 
seven have been isolated and fully characterized. However, these seven possess a diversity of 
killing mechanisms (Duquesne et al., 2007a); some are active as unmodified peptides, while 
others are heavily modified by dedicated maturation enzymes. (Duquesne et al., 2007b)
The successful use of probiotics-producing colicins, microcins, or any other 
bacteriocins requires understanding the factors influencing the frequency of bacteriocin 
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production in a bacterial population. This aspect of bacteriocin ecology was recently studied 
in clinical and environmental E. coli populations. Recent evidence indicates that the 
frequency of bacteriocin production in E. coli populations can vary from 10 to 80% 
depending on the animal host from which they were isolated (Gordon et al., 1998; Gordon 
and O'Brien, 2006), the host's diet (Barnes et al., 2007), temporal changes (Gordon et al.,
1998), and the type of bacteriocin produced by the strain. (Gordon et al., 2007) These 
observations suggest that it is not enough for antimicrobial-producing probionts to be proven 
potent against pathogens; they also need to complement the existing bacterial dynamics in the 
target host.
Bacteriocins of Gram-positive bacteria
Bacteriocins of Gram-positive bacteria are as abundant and even more diverse then those 
found in Gram-negative bacteria. The Gram-positive bacteriocins resemble many of the 
antimicrobial peptides produced by eukaryotes; they are generally cationic, amphiphilic, 
membrane-permeabilizing peptides, and range in size from 2 to 6 kDa. (Heng et al., 2007)
They differ from bacteriocins of Gram-negative bacteria in two fundamental ways. (Riley 
and Wertz 2002b) First, the bacteriocins produced by Gram-positive bacteria are not 
necessarily lethal to the producing cell. This critical difference is due to dedicated transport 
mechanisms Gram-positive bacteria encode to release the bacteriocin toxin. Typically, their 
biosynthesis is self-regulated with specifically dedicated transport mechanisms facilitating 
release, although some employ the Sec-dependent export pathway. (Drider et al., 2006; 
Eijsink et al., 2002; Maqueda et al., 2008) Second, the Gram-positive bacteria have evolved 
bacteriocin-specific regulation, whereas bacteriocins of Gram-negative bacteria rely solely on 
host regulatory networks. (Nes et al., 1996)
Bacteriocins produced by LAB, which have a long history of use in fermentation and 
meat and milk preservation, are the best characterized of this group. (Cintas et al., 2001)
Four classes of LAB antibiotics are identified: Class I is comprised of modified bacteriocins, 
known as lantibiotics (Twomey et al., 2002); class II includes heat stable, minimally 
modified bacteriocins (Drider et al., 2006; Eijsink et al., 2002); class III includes larger, 
heat-labile bacteriocins; and class IV is comprised of complex bacteriocins carrying lipid or 
carbohydrate moieties. (Heng et al., 2007) Classes I and II have been the focus of most 
probiotic research.
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Lactic acid bacteria have been employed for centuries in the fermentation of food, 
partly due to the fact that they can prevent the growth of spoilage and pathogenic 
microorganisms. (Cheigh and Pyun 2005) They produce bacteriocins, the l antibiotics, so 
named because they are post-translationally modified to contain amino acids such as thioether 
bridges of l anthionine and 3-methyllanthionine or dehydroalanin. (Twomey et al., 2002) L 
antibiotics are ribosomally synthesized bacteriocins that target a broad range of Gram-
positive bacteria and are subdivided into three groups on the basis of their structure and mode 
of action: Type A lantibiotics, such as nisin, are small (2–5 kDa), elongated, screw-shaped 
proteins that contain positively charged molecules, which kill via the formation of pores, 
leading to the dissipation of membrane potential and the efflux of small metabolites from the 
sensitive cells. (Nagao et al., 2006) Nisins have a dual mode of action: (1) They bind to lipid 
II, the main transporter of peptidoglycan subunits from the cytoplasm to the cell wall, and 
therefore prevent correct cell wall synthesis, leading to cell death, and (2) they employ lipid 
II as a docking molecule to initiate a process of membrane insertion and pore formation that 
leads to rapid cell death. (Wiedemann et al., 2001) Type B lantibiotics, such as mersacidin 
(Twomey et al., 2002), kill by interfering with cellular enzymatic reactions, such as cell wall 
synthesis. (Pag and Sahl 2002; Sahl and Bierbaum 1998; Sahl et al., 1995) Another 
subgroup is composed of two-component lantibiotics, such as lacticin 3147 (Wiedemann et 
al., 2006) consisting of two lantibiotic peptides that synergistically display antimicrobial 
activity. (Ryan et al., 1998) It was shown that the dual activities could be distributed across 
two peptides: While one resembles type B lantibiotic mersacidin, which depolarizes the 
membrane, the other is more similar to the type A lantibiotic class pore formers. (Martin et 
al., 2004)
Class II LAB bacteriocins are also small nonlanthionine-containing peptides. (Drider 
et al., 2006; Oppegård et al., 2007) The majority of bacteriocins in this group kill by 
inducing membrane permeabilization and the subsequent leakage of molecules from target 
bacteria. These bacteriocins are organized into subgroups: Class IIa is the largest group and 
its members are distinguished by shared activity against Listeria and a conserved amino-
terminal sequence (YGNGVXaaC) that is thought to facilitate nonspecific binding to the 
target surface. Like type A lantibiotics, class IIa bacteriocins act through the formation of 
pores in the cytoplasmic membrane. Examples include pediocin (this group is also called 
pediocin-like bacteriocins), sakacin A, and leucocin A. (Drider et al., 2006; Hechard and 
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Sahl 2002; Oppegård et al., 2007) Class IIb bacteriocins such as lacticin F and lactococcin 
G form pores, composed of two different proteins, in the membrane of their target cells. 
(Garneau et al., 2002; Hechard and Sahl 2002) A third subgroup (IIc) has been proposed, 
which consists of bacteriocins that are sec-dependent, such as acidocin 1B. (Han et al., 2007) 
Class III bacteriocins are large heat-labile proteins such as helveticins J or lactacin B. 
(Dobson et al., 2007; Joerger 2003) An additional proposed class (IV) requires lipid or 
carbohydrate moieties for activity. Little is known about the structure and function of this 
class. Examples include leuconocin S and lactocin 27. (Choi et al., 1999; Vermeiren et al., 
2006)
Gram-positive bacteriocins, in general, and lantibiotics, in particular, require many 
more genes for their production than do those of Gram-negative bacteria. (Nagao et al., 
2006) The nisin gene cluster, for example, includes genes for the prepeptide (nisA), enzymes 
for modifying amino acids (nisB, nisC), cleavage of the leader peptide (nisP), secretion 
(nisT), immunity (nisI, nisFEG), and regulation of expression (nisR, nisK). These gene 
clusters are most often encoded on plasmids but are occasionally found on the chromosome 
(Cheigh and Pyun 2005). Several Gram-positive bacteriocins, including nisin, are located on 
transposons. (Kim and Dunn 1997)
The conventional wisdom about the killing range of Gram-positive bacteriocins is that 
they are restricted to killing other Gram-positives. (Riley and Wertz 2002a) The range of 
killing can vary significantly, from relatively narrow as in the case of lactococcins A, B, and 
M, which have been found to kill only Lactococcus, to extraordinarily broad. (Martínez-
Cuesta et al., 2006) For instance, some type A lantibiotics, such as nisin A and mutacin B-
Ny266, have been shown to kill a wide range of organisms including Actinomyces, Bacillus, 
Clostridium, Corynebacterium, Enterococcus, Gardnerella, Lactococcus, Listeria, 
Micrococcus, Mycobacterium, Propionibacterium, Streptococcus, and Staphylococcus.
(Mota-Meira et al., 2000, 2005) Contrary to conventional wisdom, these particular 
bacteriocins are also active against a number of medically important Gram-negative bacteria 
including Campylobacter, Haemophilus, Helicobacter, and Neisseria. (Morency et al., 2001)
Production of bacteriocins in Gram-positive bacteria is generally associated with the 
shift from log phase to stationary phase. For example, nisin production begins during mid-log 
phase and increases to a maximum as the cells enter stationary phase. (Breukink and de 
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Kruijff 1999) The regulation of expression is not cell cycle dependent, per se, but rather 
culture density dependent. (Dufour et al., 2007) It has been demonstrated that nisin A acts as 
a protein pheromone in regulating its own expression, which is controlled by a two-
component signal transduction system typical of many quorum-sensing systems. (Hechard 
and Sahl 2002) The genes involved are nisR (the response regulator) and nisK (the sensor 
kinase). Nisin transcription is induced by the addition of nisin to the culture medium, with the 
level of induction directly related to the level of nisin added. (Kuipers et al., 1995)
The human GI tract is a complex ecosystem in which a delicate balance exists 
between the intestinal microflora and the host. The microflora serves as a primary stimulus 
for the development of the mucosal immune system. (Deplancke and Gaskins 2002; 
Macfarlane and Cummings 2002) Two main genera of lactic acid bacteria dominate the 
intestinal flora, including 56 species of Lactobacillus and numerous species of 
Bifidobacterium. Most of these species have been shown to produce bacteriocins in vitro.
(Avonts and De Vuyst 2001; Carr et al., 2002; Cross 2002) More recently, some of these 
strains have also been shown to produce bacteriocins in vivo. One particularly compelling 
study demonstrated the in vivo activity of Lactobacillus salivarius strain UCC118, which 
produces a potent broad-spectrum bacteriocin (Abp118) active against the food-borne 
pathogen Listeria monocytogenes. (Claesson et al., 2006) In mice, the L. salivarius strain 
provided protection against L. monocytogenes infection, while a mutant strain of the same 
species, impaired in its bacteriocin production ability, did not. Even more compelling, the 
bacteriocin-producing strain provided no protection against pathogen infection when mice 
were infected with a strain of L. monocytogenes expressing the cognate Abp118 immunity 
protein. (Corr et al., 2007)
A strain of Lactobacillus casei L26 LAFTI was shown to significantly inhibit an 
enterohemorrhagic strain of E. coli and a strain of L. monocytogenes in mice (Su et al., 
2007a, b), probably due to bacteriocin production (Pidcock et al. 2002). The release of 
bacteriocins inhibiting Helicobacter pylori, a human pathogen that causes severe 
gastroduodenal diseases (Kandulski et al., 2008), has been chiefly studied in lactobacilli 
strains. A BLIS with anti-H. pylori activity was identified in probiotic Lactobacillus 
johnsonii strain LA1 (Gotteland et al., 2008; Michetti et al., 1999) and Lactobacillus 
acidophilus strain LB. (Coconnier et al., 1998) In both cases, the inhibitory activity was 
retained when H. pylori was bound to intestinal epithelial cells. Oral administration of L. 
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acidophilus LB in mice protected the animals from infection with Helicobacter felis.
(Coconnier et al., 1998; Nedrud and Blanchard 2001) This PB was further shown to 
inhibit gastric colonization and prevent the development of gastric inflammation. (Coconnier 
et al., 1998) Administration of L. johnsonii LA1 supernatant to adult patients colonized by H. 
pylori significantly decreased infection (Gotteland et al., 2008; Gotteland and Cruchet
2003), while oral consumption of the live bacteria by school children, which were found to be 
H. pylori positive, resulted in a significant decrease in urease production. (Cruchet et al., 
2003) Mutacin B-Ny266, a lantibiotic produced by Streptococcus mutans, was recently 
shown to inhibit a broad spectrum of multi-resistant pathogens including staphylococci, 
streptococci, and Neisseria strains (Mota-Meira et al., 1997, 2000; Parrot et al., 1990) and 
was found active against methicillin-resistant Staphylococcus aureus when assayed in a 
mouse model. (Mota-Meira et al., 2005)
Most of the members of class IIa bacteriocins have relatively narrow killing spectra 
compared to those in class I and inhibit only closely related Gram-positive bacteria. (Heng et 
al., 2007) However, there are exceptions, such as pediocin, which has a fairly broad 
inhibitory spectrum and can inhibit Streptococcus aureus and vegetative cells of Clostridium
spp. and Bacillus spp. and Listeria. (Cintas et al., 1997; Eijsink et al., 2002; Nes and Holo, 
2000; van Reenen et al., 1998) A pediocin-producing strain of Pediococcus acidilactici, able 
to survive in the GI tract, was recently isolated and found to be an effective inhibitor of 
several Gram-positive bacterial pathogens, such as Enterococcus spp. (including 
vancomycin-resistant strains) and L. monocytogenes. Furthermore, it inhibited gastric 
adhesion of opportunistic pathogens from Klebsiella, Pseudomonas, and Shigella genera. 
(Piva and Casadei 2006; Speelmans et al., 2006) Another promising probiont is the 
bacteriocin producer Enterococcus mundtii strain ST4SA, active against a number of Gram-
positive bacteria, including Enterococcus faecalis, Streptococcus pneumoniae, and 
Staphylococcus aureus, as well as the Gram-negative bacteria P. aeruginosa and K. 
Pneumonia. (Granger et al., 2008) The survival, persistence, and bacteriocin production of 
this strain were successfully evaluated within the GI tract of pigs.
Weakness of the bacteriocins produced by Gram-positive bacteria, with respect to 
their use in probiotic applications, is that they seldom inhibit commonly encountered 
enteropathogenic bacteria such as Enterobacter, Klebsiella, or Salmonella. However, 
bacteriocins produced by Gram-negative bacteria can accomplish this task. For example, E. 
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coli strain H22 inhibited the growth of seven genera of the family Enterobacteriaceae
(Enterobacter, Escherichia, Klebsiella, Morganella, Salmonella, Shigella, and Yersinia). The 
observed inhibition was attributed to the production of microcin C7 (Smajs et al., 2008) and 
colicins E1 and Ib, as well as aerobin and an unidentified phage. (Cursino et al., 2006)
Simultaneous administration of the probiont and the enteric pathogen Shigella flexneri to 
germ-free mice resulted in a strong inhibition of the pathogen, which was attributed to its 
microcin production. (Cursino et al., 2006) A more widely used enteric probiont is E. coli
strain Nissle 1917, originally isolated from the feces of a soldier who did not develop 
diarrhea during a severe outbreak of shigellosis. (Snelling 2005) Some of the beneficial 
properties of this strain may be attributable to bacteriocin production, as this strain was 
shown to produce two microcins, H47 and M. (Patzer et al., 2003) 
The bacteriocin activity includes other species of lactobacilli, as well as a variety of 
Gram-positive and Gram-negative aerobic, facultative, and obligate anaerobic bacteria. It is 
significant that one species of Lactobacillus will produce a bacteriocin that inhibits the 
growth of other lactobacilli. This may be one mechanism that allows Lactobacillus to 
dominate the ecosystem by suppressing not only other bacteria but also other lactobacilli. 
This in turn reduces competition within an ecosystem.
Although bacteriocins may be found in many Gram-positive and Gram-negative 
bacteria , those produced by LAB have received particular attention in recent years due to 
their potential application in the food industry as natural preservatives. Bacteriocins produced 
by LAB are small, ribosomally synthesized, antimicrobial peptides or proteins that possess 
activity towards closely related.Gram-positive bacteria, whereas producer cells are immune to 
their own bacteriocin(s). (De Vuyst 2007)
An adhesion-promoting protein involved in the binding of Lactobacillus fermentum
strain 104R to small intestinal mucus from piglets and to partially purified gastric mucin was 
isolated and characterized. Spent culture supernatant fluid and bacterial cell wall extracts
were fractionated by b and gel filtration. The active fraction was purified by affinity 
chromatography. The adhesion-promoting protein was detected in the fractions by adhesion 
inhibition and dot blot assays and visualized by polyacrylamide gel electrophoresis (PAGE), 
sodium dodecyl sulfate-PAGE. (Maurilia R. et al., 2002)
Lactobacillus acidophilus 30SC was tested for its potential as a probiotic culture.  The 
strain produced a heat-stable antimicrobial compound that was shown to be proteinaceous in 
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nature and, therefore, referred to as a bacteriocin. The bacteriocin was active over a wide pH 
range and inhibited a number of Gram-positive bacteria including Listeria ivanovii and 
pathogenic strains. The bacteriocin was purified by 50% ammonium sulfate precipitation 
followed by hydrophobic interaction column chromatography. The SDS-PAGE of the active 
fractions resulted in a single band with estimated molecular mass of 3.5 kDa.
Bacteriocin producing Lactobacillus acidophilus strain was isolated from the gut of 
marine prawn (Penaeus monodon). This bacteriocin has broad range of antibacterial activity 
against major food born pathogens. Maximum bacteriocin production was observed at 
temperature 50°C, pH 4 and 0.9% sodiummchloride & it was purified by ammonium sulphate 
precipitate . Dialysis was followed in a tubular cellulose membrane (1000 cut off) against 2L 
distilled water for 24 h, Molecular size of bacteriocin was determined using b gel following 
the procedure of Sambrro et al. (2006) was 2.5 KDa. This study revealed the possibility of 
using bacteriocin as a food preservative and the L. acidophilus strain as probiotic.
Bacteriocin producing Lactobacillus lactis strain isolated from marine environment, 
showed broad range of antibacterial activity against some major food borne pathogens. 
Maximum bacteriocin production was observed at 30°C, pH 6.0 and 1.5% sodium chloride 
solution. The crude bacteriocin was precipitated with 80% ammonium sulphate. The 
precipitate was dialysed against 20 mM potassium phosphate buffer (pH 7.0) for 12 h at 4ºC. 
The molecular weight of the bacteriocin was determined by 15% SDS-PAGE, was 94 kDa. 
The study revealed the possibility of using bacteriocin as a food preservative and the L. lactis 
strain as probiotic. (G. Rajaram. et al., 2010)
MOLECULAR IDENTIFICATION OF PROBIOTIC STRAINS
Methods used for detection of probiotics in human gastrointestinal tract are
identification of colony morphology, fermentation patterns, serotyping or some combination 
of these. Although these traditional methods have limitations they are used for identification. 
With the developing technology about the molecular typing it is getting more reliable to 
identify and differentiate bacterial strains. Classical microbiological techniques are really 
important for selection, enumeration and biochemical characterization (fermentation profiles, 
salt-pH-temperature tolerances) but it is not efficient to classify a culture taxonomically. 
Molecular characterization methods are powerful even between closely related species. There 
are number of alternative taxonomic classification methods well known including 
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hybridization with species-specific probes and generation of profile PCR applicants by 
species-specific primers. (Klaenhammer and Kullen 1999) Polymerase chain reaction based 
methods (PCR-RFLP, REP-PCR, PCR ribotyping and RAPD) are mainly used as molecular 
tools. (Bulut 2003) Comparison between these methods, the most powerful and accurate one
is sequencing. (Coeuret et al., 2003)
Characterization of microorganisms according to their 16S rDNA regions sequencing 
was firstly proposed by Woese in 1987. The application of 16S or 23S rRNA-targeted 
oligonucleotide probes is the best and most reliable approach to identify bacteria on a 
phylogenetic basis. The 16S rRNA gene is nearly 1540 bases long and includes variable 
regions while the general structure is highly conserved. Because the probes have the broadest 
specificity ranging from universal to species specificity, it is possible to use 16S rRNA gene 
to study phylogenetic relationships between microorganisms and identify them more 
accurately. (Çakır 2003, Holzapfel et al., 1998, Charteris et al., 1997)
In one study, the PCR-ARDRA technique was used to identify potential probiotic 
Lactobacillus species isolated from bovine vagina. 16S rRNA gene was amplified by PCR 
and products were digested with four restriction enzymes (Sau 3AI, Hinf I, Hinc II and Dra 
I). Most of the digestion profiles obtained from the amplified 16S rDNA gene of these strains 
agreed with the theoretical profile matching with Lactobacillus fermentum. Among all 
strains, four homofermentative lactobacilli showed a restriction profile that matched with 
Lactobacillus gasseri and a facultative heterofermentative strain was identified as 
Lactobacillus rhamnosus. (Otero et al., 2006)
Restriction enzyme analysis were done by using pulsed with gel electrophoresis
(REA-PFGE) and intergenic transcribed spacers (ITS)-PCR restriction fragment length
polymorphism (RFLP) techniques for identification of probiotic potential strains (by
sequencing of the 16S rRNA gene) isolated from koko and koko sour water (African
spontaneously fermented millet porridge and drink). Taq I and Hae III restriction enzymes 
were used for digestion. From the result of ITS-PCR RFLP, four groups were obtained 
including group 1 Weisella confuse, group 2 Lactobacillus fermentum, group 3 Lactobacillus 
salivarus and group 4 Pediococcus spp. At the end it was showed using for identification of 
these strains the ITS-PCR RFLP technique, 16S rRNA gene sequencing is very reliable. (Lei 
and Jakobsen 2004)
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To identify lactobacilli used as starter and probiotic cultures, amplified ribosomal 
DNA restriction analysis (ARDRA) was applied. Firstly group-specific and species-specific 
16S rDNA primers were used to amplification. Cfo I, Hinf I, Tru 91 and ScrFI restriction 
enzymes were selected for digestion. The results revealed three groups: A, B and C. It is 
suggested that ARDRA by using Cfo I was reliable method for differentiation of L. 
delbrueckii subsp. bulgaricus and L. delbrueckii subsp. Lactis. (Roy et al., 2001)
Some researchers aimed to develop a novel multiplex PCR primer set to identify
seven probiotic Lactobacillus species (L.acidophilus, L. delbrueckii, L.casei, L.gasseri, L. 
plantarum, L. reuteri and L. rhamnosus). The primer set containing seven specific and two
conserved primers, was obtained from the integrated sequences of 16S and 23S rRNA genes 
and their rRNA intergenic spacer region of each species. 93.6% accuracy was obtained to 
identify the seven target species. The study showed that the multiplex primer set is really 
efficient tool for simple, rapid and reliable identification of Lactobacillus species. (Kwon et 
al., 2004)
In another study potential probiotic Lactobacillus strains isolated from human, animal 
and food were identified by 16S-23S rRNA restriction profiling at species level. Firstly PCR 
amplification of 16S-23S rRNA intergenic spacers was done by using universal primers. It is 
followed by digestion of PCR products by 11 restriction enzymes with 6bp specificities. 
Some of the enzymes were Sfu I, Hind III, Dra I, EcoRI, EcoRV etc. the study was concluded 
that identification could be done by DNA fingerprints generated by restriction endonucleases. 
The amplified ribosomal DNA restriction analysis (ARDRA) was an easier, faster and more 
accurate method. (Moreire et al., 2005)
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ENRICHMENT AND ISOLATION
 Sterilization of glass ware
The sterilization of glasswares such as sampling bottles, flasks, petridishes and test 
tubes after washing with detergent was carried out in hot air oven at 160°C for 2hours. (Harrigan 
1998)
 Sample collection
Isolation carried out from stool sample of 1-2 year old baby, vaginal sample & curd 
sample as well as from milk sample. Bacteria were isolated by using enrichment techniques in 
MRS broth. The samples were stored under refrigeration conditions for subsequent experiments.
 Media preparation
Nutrient agar, nutrient broth, de Man, Rogosa and Sharpe (MRS) agar and de Man, 
Rogosa and Sharpe (MRS) broth, used for bacterial growth were prepared according to the 
methods recommended by Harrigan and McCance (1976) and Harrigan (1998). The pH of 
media was adjusted by using 0.1N NaOH and 0.1N HCl. 
 MRS broth
This was the selective medium used for the isolation and enumeration of   
Lactobacillus spp:  Composition of MRS Broth:
The ingredients were dissolved 51 g in distilled water and the pH was adjusted at 6.2 to 6.6 
and then medium was sterilized at 121°C for 15 minutes, under 15Ib pressure.
Composition: Ingredients Quantity (g) Grams/Litre
Peptone 10.0
Meat extract 8.0
Yeast extract 4.0
D(+)-Glucose 20.0
Dipotassium hydrogen phosphate 2.0
Sodium acetate trihydrate 5.0
Triammonium citrate 2.0
Magnesium sulfate heptahydrate 0.2
Manganous sulfate tetrahydrate 0.05
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 MRS agar
MRS agar was prepared by adding 1.5% agar agar in MRS broth (prepared above) and 
was then autoclaved.   
 Inoculation and incubation
The samples inoculated into MRS broth and incubated at 37oc for 48hrs than transfer 
subsequently to MRS agar for isolation and purification.
COLONY CHARACTERIZATION OF ISOLATES
 Colony Characteristics
The typical colonies on MRS agar were sub-cultured on the same medium again and 
again until a pure growth for each culture isolate was obtained.
The colony characteristics of isolates were studied on MRS agar medium.
MORPHOLOGICAL CHARACTERIZATION
Morphological examinations to characterize the isolates on the basis of cell     
arrangement as well as cell size and shape were performed by Gram staining.
BIOCHEMICAL CHARACTERIZATION OF ISOLATES
All the biochemical tests Performed according to Bergey’s manual, media were 
inoculated with respective test organisms and incubated at 37 °C for 24 hours and results were 
subsequently observed. 
DETERMINATION OF ANTIBACTERIAL ACTIVITY OF ISOLATES
Antibacterial activities of isolates were carried out in n-agar plates by well –diffusion 
assay. Cultures were activated in N broth. Isolates were inoculated in MRS broth and incubated 
at 37o c for 24hrs for activation of cultures and then centrifuged at 3000 rpm for 15min and 
supernatant was collected to study antibacterial activity. Zone of diameter was measured and then 
with the help of that zone index was calculated.
Assay procedure: 0.2ml of activated test cultures was inoculated in molten agar and poured in 
sterile plates than allowed to solidify. Wells were prepared at equal distance in solidified agar 
plates using cup-borer. The plates were incubated at 37oc for 24hrs to observe zone inhibition.
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DETERMINATION OF ANTIBIOTIC SUSCEPTIBILITY 
All the isolates were studied for their antibiotic susceptibility. Span diagnostic octadisc 
was used to study antibiotic susceptibility.
         Zone of inhibition was measured. Growth indicates resistance and no growth indicates 
sensitivity towards antibiotics.
BILE SALT TOLERANCE
MRS Broth with 1%,2%,3%,4%  Bile salt (w/v) were inoculated with a 0.1ml 
activated culture of bacteria(stool and vaginal samples were selected) and incubated at 37oC for 
48 hrs. Growth of the organism measured calorimetrically at 540 nm.
NaCl TOLERANCE
MRS Broth with 1%,2%,3%,4% NaCl (w/v) were inoculated with a 0.1ml 
activated culture of bacteria isolated from stool and vaginal samples and incubated at 37oC for 
48 hrs. Growth of the organism measured calorimetrically at 540 nm.
pH TOLERANCE    
MRS Broth with pH  2,3,4,5,6  were inoculated with a 0.1ml activated culture 
of bacteria incubated at 37oC for 48 hrs. Growth of the organism measured calorimetrically at 
540 nm.
STUDY OF GROWTH AND GROWTH CURVE OF ISOLATES   WITH   
DIFFERENT PARAMETERS
 GROWTH IN MRS BROTH AND MRS BOTH + INULIN
MRS broth with 0.5 and 1% Inulin were inoculated with a 0.1 ml of activated 
culture and incubated at 37.c for 48 hrs. Growth of the organism measured 
calorimetrically at 540nm.
 GROWTH CURVE OF STOOL SAMPLE WITH MRS BROTH AND MRS 
BROTH + INULIN
On the basis of result of antibacterial activity 6 isolates of stool  sample were 
selected. Growth curve of the Isolates was performed.
After inoculation 0min. O.D was taken at 540nm. Then the flasks were 
incubated at 370C and O.D was taken at regular interval. 
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 GROWTH CURVE FOR VAGINAL SAMPLE WITH MRS BROTH AND MRS 
BROTH + INULIN
On the basis of result of antibacterial activity 6 isolates of vaginal  sample were 
selected. Growth curve of these Isolates were inoculated in  simple MRS  broth with 
compare to  MRS broth with 1%inulin. 
After inoculation 0min. O.D was taken at 540nm. Then the flasks were incubated 
at 370C and O.D was taken at every 30min for 2hour. Then O.D was taken at every 
1hour interval.
 GROWTH CURVE WITH MRS BROTH, MRS BROTH WITH PH- 3 AND 1% 
BILE SALT
On the basis of result of antibacterial activity of both stool and vaginal sample 
isolates were selected
After inoculation at 0min. O.D was taken at 540nm. Then the flasks were 
incubated at 370C and O.D was taken at every 30min for 2hour. Then O.D was taken at 
every 1hour interval.
PURIFICATION AND CHARACTERIZATION OF BACTERIOCIN
 Activation of isolates: Colony of isolates were inoculated in 150ml MRS broth & 
incubated at 370c for 24 hrs. 
 Ammonium sulphate precipitation: After 24 hrs, the activated culture was treated 
with ammonium sulphate as 20, 40, 60, & 80% (w/v) saturation to precipitate crude 
protein & then centrifuged at 10,000 rpm for 10 min. after that precipitate were 
resuspended in 10ml, 20mM phosphate buffer (pH-7).
Composition of phosphate buffer:
Solution-A 
0.2M monobasic sodium phosphate(27.8gm/1000 ml)
Solution-B
0.2M dibasic sodium phosphate (53.65gm of Na2HPo4.7h2o/1000 ml). Mix39.0ml of 
solution-A with 61.0ml of solution-B & make final volume up to 200 ml to get working 
solution of 0.2 M phosphate buffer.
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DIALYSIS
Dialysis was followed in a tubular cellulose membrane (1000 cut off) against 1L of 
0.2 M Acetate buffer by constant stirring at 40c for 24 h, from which the Sodium dodesyl 
sulphate polyacrlylamide gel electrophoresis was performed.
SDS-PAGE
Stock solution Stacking 
gel (2.5%)
Resolving 
gel (12.5%)
Acrylamide:Bisacrylamide (30:0.8) 2.5ml 12.5ml
Stacking  gel buffer stock (trisHCl, pH-6.8) 5.0ml -
Resolving gel buffer stock (tris HCl, pH-8.8) - 3.75ml
10% SDS 0.20ml 0.3ml
1.5%  Ammonium per sulphate 1ml 1.5ml
TEMED 0.02ml 0.02ml
Water 11.30ml 11.95ml
MAINTENANCE OF CULTURES: 
The pure cultures were maintained at refrigeration temperature with a continuous sub 
culturing techniques on MRS agar. 

Total 33 different isolates were obtained on MRS agar plates 
for their morphological and biochemical characterization.
isolates were selected for further isolation and purification. 
The isolates were then subjected to the test for 
isolates were further studied for Biochemical Reactions.
Vaginal swab 
isolates
Mother milk  
isolates-
Numbers of Isolates obtained from different natural samples
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which were further studied 
Gram positive and rod shaped 
Catalase production. Catalase 
Curd isolates-
4
Stool  sample 
isolates-9
sample 
- 12
5
Yoghurt
isolates-3
Graph:1
negative
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Colony characteristics of all the isolates revealed few common characters
Table-1:  Colony Characterization of isolates from Curd Samples
COLONY 
CHARACTERISTICS
ISOLATES
PC Cub Cuc Cue
Size Small Small Small Small
Shape Circular Circular Circular Circular
Margin Round Regular Regular Regular
Texture Smooth Glistering Glistering Glistering
Elevation Raised Raised Raised Raised
Opacity Opaque Opaque Opaque Opaque
Pigmentation Grayish white White White White
Table: 2 (a) Colony Characterization of isolates from Stool Sample
COLONY
CHARACTERISTICS
ISOLATES
S5b S1 S2 S-1 S-2
Size Small Small Small Small Small
Shape Circular Circular Circular Convex Circular
Margin Regular Undulate Regular Regular Regular
Texture Glistering Smooth Glistering Smooth Glistering
Elevation Raised Raised Raised Raised Raised
Opacity Opaque Opaque Opaque Opaque Opaque
Pigmentation White Dull White White White
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Table: 2(b) Colony Characterization of isolates from Stool Sample
COLONY 
CHARACTERISTICS
ISOLATES
RB-b RB-c RB-II RB-III A B
Size Small Small Small Small Small Small
Shape Circular Circular Circular Circular Circular Circular
Margin Regular Entire Entire Regular Entire Regular
Texture Glistering Smooth Glistering Mucoid Smooth Smooth
Elevation Raised Raised Raised Raised Raised Raised
Opacity Opaque Opaque Opaque Opaque Opaque Opaque
Pigmentation White Creamish 
white
White White Creamish 
white
White
Table: 3(a) Colony Characterization of isolates from Vaginal Sample
COLONY 
CHARACTERISTICS
ISOLATES
VaR2 Vag Vg5b Vg5c Vg5d Vg5e
Size Small Small Small Small Small Small
Shape Circular Convex Circular Convex Circular Circular
Margin Regular Regular Regular Regular Regular Regular
Texture Mucoid Smooth Smooth Smooth Mucoid Glistering
Elevation Raised Raised Raised Raised Raised Raised
Opacity Opaque Opaque Opaque Opaque Opaque Opaque
Pigmentation White White White White White White
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Table: 3(b) Colony Characterization of isolates from Vaginal Sample
COLONY 
CHARACTERISTICS
ISOLATES
Vg6a Vg6b Vg6c Vg1 Vg2 Vgf
Size Small Small Small Small Small Small
Shape Circular Circular Circular Circular Circular Circular
Margin Regular Regular Entire Undulate Regular Regular
Texture Smooth Mucoid Mucoid Smooth Mucoid Mucoid
Elevation Raised Raised Raised Raised Raised Raised
Opacity Opaque Opaque Opaque Opaque Opaque Opaque
Pigmentation White White White Dull White White
Table: 4 Colony Characterization of isolates from Yogurt Sample
COLONY CHARACTERISTICS ISOLATES
Yg1 Yg2 Yg3
Size Small Small Small
Shape Circular Convex Circular
Margin Regular Regular Regular
Texture Mucoid Smooth Glistering
Elevation Raised Raised Raised
Opacity Opaque Opaque Opaque
Pigmentation White White White
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Table: 5 Colony Characterization of isolates from Milk sample
COLONY CHARACTERISTICS ISOLATES
Milk 1-C 3
Size Small Small Small
Shape Convex Circular Circular
Margin Regular Regular Regular
Texture Smooth Smooth Glistering
Elevation Slightly Raised Raised Slightly Raised
Opacity Opaque Opaque Opaque
Pigmentation White White White
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Out of 33 Isolates, 23 isolates were cocci and 10 isolates were rod in shape.      
Table: 6 Gram staining of rod shaped cells 
Figure Rod
Vag, Vg5c, Vg1
S1, S2, S-I, S-II
Milk
Cub
Yg2
Table: 7 Gram staining of cocci
Figure Cocci
VaR2, Vg5b , Vg5d,  Vg5e, 
Vg6a, Vg6b, Vg6c, Vg2, Vgf
S5b,RB-b, RB-c, RB-II,RB-
III A, B
Pc, Cuc, Cue
3, 1C
Yg1, Yg3
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Table No: 8 Cell Morphology and Arrangement
          Characters
Isolates
No.      Name
Shape Arrangement Capsule Spore
1 PC Cocci In pair and tetrad -Ve -Ve
2 Cub Long rod Single and few in pair -Ve -Ve
3 Cuc Cocci Single and in pair -Ve -Ve
4 Cue Cocci In pair and tetrad -Ve -Ve
5 S5b Cocci Single and in pair -Ve -Ve
6 S1 Long rod In chain and single -Ve -Ve
7 S2 Short rod Single -Ve -Ve
8 S-I Long rod In chain and single -Ve +Ve
9 S-II Short rod Single -Ve -Ve
10 RB-b Cocci Single and in pair -Ve -Ve
11 RB-c Cocci Single and in pair -Ve -Ve
12 RB-II Cocci Single and in pair -Ve -Ve
13 RB-III Cocci Single and in pair -Ve -Ve
14 A Cocci In pair and tetrad -Ve -Ve
15 B Cocci In pair and tetrad -Ve -Ve
16 Vag Long rod Single and pair -Ve -Ve
17 VaR2 Cocci Single and Tetrad -Ve -Ve
18 Vg5b Cocci Single and in pair -Ve -Ve
19 Vg5C Long rod Single and in pair -Ve -Ve
20 Vg5d Cocci In pair and tetrad -Ve -Ve
21 Vg5e Cocci In pair and tetrad -Ve -Ve
22 Vg6a Cocci In pair and short chain -Ve -Ve
23 Vg6b Cocci In pair and Short chain -Ve -Ve
24 Vg6C Cocci Single and in pair -Ve -Ve
25 Vg1 Long rod In chain and single -Ve +Ve
26 Vg2 Cocci In pair and tetrad -Ve -Ve
27 Vgf Cocci In pair and tetrad -Ve -Ve
28 MILK Short rod Single and in pair -Ve -Ve
29 3 Cocci In pair and single -Ve -Ve
30 1C Cocci Tetrad and in pair -Ve -Ve
31 Yg1 Cocci In pair and single -Ve -Ve
32 Yg2 Long rod Single and in pair -Ve -Ve
33 Yg3 Cocci Tetrad and short chain -Ve -Ve
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Different biochemical test were performed for the primary differentiation among the 
isolates.
Table: 9 (a) Biochemical Characterization of Isolates
Number Isolates
Starch 
Utilization
Citrate 
utilization
Casein 
Hydrolysis
Gelatin 
Hydrolysis
1 PC - - - -
2 Cub - - - -
3 Cuc - - - -
4 Cue - - - -
5 S5b - - - -
6 S1 - - - -
7 S2 - - - -
8 S-1 - - - -
9 S-2 - - - -
10 RB-b - - - -
11 RB-c - - - -
12 RB-II - - - -
13 RB-III - - - -
14 A - - - -
15 B - - - -
16 Vag - - - -
17 VaR2 - - - -
18 Vg5b - - - -
19 Vg5C - + - -
20 Vg5d - - - -
21 Vg5e - + - -
22 Vg6a - - - -
23 Vg6b - - - -
24 Vg6C - - - -
25 Vg1 - - - -
26 Vg2 - - - -
27 Vgf - - - -
28 MILK - - - -
29 3 - - - -
30 1C - - - -
31 Yg1 - - - -
32 Yg2 - - - -
33 Yg3 - - - -
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Table: 9 (b) Biochemical Characterization of Isolates
Number Isolates
MR 
test
VP
test
H2S 
Production
Indole 
Production
Ammonia 
Production
Nitrate 
Reduction
Urea 
utilization
1 PC - - - - - - -
2 Cub + - - - - - -
3 Cuc + - - - + - -
4 Cue + - - - + - -
5 S5b + - - - - - -
6 S1 + - - - - - -
7 S2 + - - - - - -
8 S-1 + - - - - - -
9 S-2 + - - - - - -
10 RB-b + - - - - - -
11 RB-c + - - - - - -
12 RB-II + - - - - - -
13 RB-III + - - - - - -
14 A + - - - - - -
15 B + - - - - - -
16 Vag + - - - - - -
17 VaR2 + - - - - - -
18 Vg5b + - - - - - -
19 Vg5C - - - - - - -
20 Vg5d + - - - - - -
21 Vg5e + - - - - - -
22 Vg6a - - - - - - -
23 Vg6b + - - - - - -
24 Vg6C + - - - - - -
25 Vg1 + - - - - - -
26 Vg2 + - - - - - -
27 Vgf + - - - - - -
28 MILK + - - - - - -
29 3 + - - - - - -
30 1C + - - - - - -
31 Yg1 + - - - - - -
32 Yg2 + - - - - - -
33 Yg3 + - - - - - -
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Catalase Test
Litmus Milk Test
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Table no: 10 Sugar fermentation test
Sugar fermentation: Acid Production
No.
Culture 
Name
Glu Xyl Suc Lac Mal Man Gal Fru Ara Raf Rham
1 PC - + + - + + + + + - -
2 Cub - + + + + + + + + + -
3 Cuc - + + + + + + + + + -
4 Cue + + + + + + + + + + -
5 S5b - + + + + + + + + - -
6 S1 - + + + + + + + + + -
7 S2 - + + + + + + + + + -
8 S-1 - + + + + + + + + + -
9 S-2 - + + + + + + + + + -
10 RB-b - + + + + + + + + + -
11 RB-c + + + + + + + + + + -
12 RB-II + + + + + + + + + - -
13 RB-III + + + + + + + + + - -
14 A + + + + + + + + + + -
15 B - + + + + + + + + + -
16 Vag - + + + + + + + + - -
17 VaR2 - + + + + + + + + - -
18 Vg5b + + + + + + + + + - -
19 Vg5C - + + + + + + + + + -
20 Vg5d - + + + + + + + + - -
21 Vg5e - + + + + + + + + - -
22 Vg6a - + + + + + + + + + -
23 Vg6b - + + + + + + + + - -
24 Vg6C + + + + + + + + + + -
25 Vg1 - + + + + + + + + - -
26 Vg2 + + + + + + + + + - -
27 Vgf - + + + + + + + + - -
28 MILK + + + - + + + + + + -
29 3 + + + + + + + + + + -
30 1C + + + + + + + + + - -
31 Yg1 + + + + + + + + + - -
32 Yg2 + + + + + + + + + + -
33 Yg3 + + + - + + + + + - -
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Sugar utilization by Isolates
Sucrose
Glucose
Xylose
Lactose
Maltose
Fructose
23%
23%
8%
23%
23%
33%
37%
12%
9% 9%
33%
37%
12%
9% 9%
33%
37%
12%
9% 9%
stool vaginal curd yogurt milk
33%
37%
12%
9% 9%
33%
40%
13%
7% 7%
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Sugar utilization by Isolates
Arabinose
Mannitol
Rhamnose
Raffinose
Galactose
33%
37%
12%
9%
9%
33%
37%
12%
9% 9%
47%
17%
18%
6% 12%
stool
vaginal
curd
yogurt
milk
33%
37%
12% 9%
9%
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On the basis of Cell Morphology, Colony characterization and all Biochemical tests 
performed all 33 isolates were selected for further study. The identification of isolates 
was performed according to the criteria of Bergey’s Manual of Determinative 
Bacteriology and using the methods and criteria of Sharpe (1979).
Ability to ferment different carbohydrates was determined on MRS-BCP broth medium, 
by using the different sugars as carbon source, which was added to the sterile basal 
medium to get final concentration 1% w/v. Carbohydrates utilization was evaluated after
24 and 48 h. Fermentation of sugar provided to isolates studied which indicates, isolates 
can utilise provided sugars except rhamnose. According to Bergey’s manual many 
probiotics can not utilise rhamnose. Gas production from glucose was assessed by 
inoculation of cultures into 5 mL MRS broth containing inverted Durham tubes and 
incubating at 35°C for 2 days.
After Biochemical characterization isolates were studied for their survival and growth in 
presence of different concentration of Bile and Acid as well as with different NaCl 
concentration. 
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STUDY OF GROWTH KINETICS
Gram positive and catalase negative isolates were preserved on MRS agar plates were selected for 
further study. Tolerances to bile and acid and growth in presence of NaCl are the most important 
properties for selection of potential probiotic strains as well as study was carried out with different 
concentrations of inulin.
1) GROWTH OF ISOLATES WITH  DIFFERENT BILE SALT CONCENTRATIONS:
Graph: 2a shows survival and growth of curd isolates in presence of different concentrations
of Bile salt. All the isolates have been found to survive in presence of 1%, 2%, 3% and 4% bile salt 
Isolate Pc shows better growth as compared to other three isolates. This indicates that Pc can be 
selected as potential candidate for the construction of a consortium for oral administration of 
probiotics. 
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Graph: 2b shows survival and growth of Milk isolates in presence of different bile salt 
concentrations. Graph indicates isolate 1C to be better survived in presence of different bile salt 
concentrations as compared to other isolates. Survival and tolerance of milk bacteria in presence of 
bile is significant because after birth stomach colonization of friendly bacteria takes place. 
Probiotics are the organism which reaches the intestine of neonatal via mother milk and provide 
health benefits. 
Graph: 2c Shows survival and growth of yoghurt isolates in presence of different bile salt 
concentrations. Yg1, Yg2 and Yg3 are the isolates obtained from Yoghurt sample. Graph indicates 
Yg1 grows best as compared to other two isolates. The bile resistant traits of intestinal yoghurt 
isolates are crucial for maintaining viability during GI transit and are desirable attributes of an 
orally administered probiotic.
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Graph: 2d1 to 2d11: Growth of Stool Sample isolates at different Bile salt concentrations
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Graph: 2d1 to 2d11 shows Survival and Growth of Stool sample isolates at different Bile 
salt concentrations. Graph 2d1 Shows survival of S5b in different bile salt concentrations. Graph 
shows only survival in 1%,2% and 3% Bile salt concentrations while in 4% bile salt concentrations
comparative good growth. Similar pattern of survival and growth is observed in Graph no: 2d3, 
2d4, 2d6, 2d7, 2d8 and in 2d10 isolates named as S2, SI, RB-b, RB-c,RB-II and A.While Graph 
2d2 indicates only the survival of S1 in presence of different bile salt concentrations. No growth is 
observed in 4% Bile salt concentrations and in 1%, 2% and 3% Bile salt concentrations only 
survival is found for SII isolate which can be observed from graph no. 2d5.Graph number 2d9 and 
2d11 indicates not only survival but good growth of RBIII and B isolates.
So it can be said that Bile may act as a stimulatory molecule as majority of the isolates show 
only survival at lower concentration but growth at higher concentrations. This could be the reason 
for their growth in the intestinal tract.
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Graph: 2e1 to 2e12: Growth of Vaginal Swab Sample isolates at different Bile salt 
concentrations
0
0.5
1
1.5
2
2.5
1% 2% 3% 4%
O
.D
 a
t 5
40
 n
m
Bile Salt Concentration
Graph:2e1
Growth of VaR2 with different Bile 
salt Concentration
0
0.5
1
1.5
2
2.5
1% 2% 3% 4%
O
.D
 a
t 5
40
 n
m
Bile Salt Concentration
Graph:2e2
Growth of Vag with different Bile 
salt Concentration
0
0.5
1
1.5
2
2.5
1% 2% 3% 4%
O
.D
 a
t 5
40
 n
m
Bile Salt Concentration
Graph:2e3
Growth of Vg5b with different Bile 
salt Concentration
0
0.5
1
1.5
2
2.5
1% 2% 3% 4%
O
.D
 a
t 5
40
 n
m
Bile Salt Concentration
Graph:2e4
Growth of Vg5C with different Bile 
salt Concentration
0
0.5
1
1.5
2
2.5
1% 2% 3% 4%
O
.D
 a
t 5
40
 n
m
Bile Salt Concentration
Graph:2e5
Growth of Vg5d with different Bile 
salt Concentration
0
0.5
1
1.5
2
2.5
1% 2% 3% 4%
O
.D
 a
t 5
40
 n
m
Bile Salt Concentration
Graph:2e6
Growth of Vg5e with different Bile 
salt Concentration
                 Results and Discussion
67
Graph: 2e1 to 2e12 shows Survival and Growth of Vaginal sample isolates at different Bile 
salt concentrations. Graph 2e1, 2e2, 2e5, 2e6, 2e8, 2e9, 2e10 and 2e11 shows survival as well as 
good growth of VaR2, Vag, Vg5d, Vg5e, Vg6b, Vg6c, Vg1 and Vg2 in different bile salt 
concentrations. Graph 2e3 and 2e4 shows only survival but poor growth of isolates with different 
bile salt concentrations and Graph 2e7 shows growth in 1% bile salt concentrations and only 
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survival in other concentrations.  Graph 2e12 indicates growth of Vgf in 3% and 4% bile salt 
concentrations while only survival in 1% and 2% bile salt concentrations. 
Out of 33 isolates, PC from curd sample, 1C from milk sample,  Yg1 from yoghurt sample, 
RBIII and B from stool sample and eight cultures VaR2, Vag, Vg5d, Vg5e, Vg6b, Vg6c, Vg1 and 
Vg2 from vaginal samples have given survival and good growth with each bile salt concentrations. 
Like bile tolerance, acid tolerance is also significant character for probiotics. Intestinal tract 
or gut is an area where acidic pH is there. The effect of pH on the growth and bile tolerance of the 
selected isolates were also studied. The strains resistant to low acidic  pH were screened for their 
ability to tolerate the bile salt. Although the bile concentrations of the human gastro intestinal tract 
varies, the mean intestinal bile concentrations is believed to be 0.3% w/v and the staying time is 
suggested to be 4 h (Prasad, et al. 1998).
2) GROWTH OF ISOLATES AT DIFFERENT pH
Graph 3a shows that each isolate of curd sample is able to grow at pH2, to pH7, except Cue 
which could not grow at pH2. Favourable growth is observed at pH5, pH6 and pH7, while at pH2, 
pH3 and pH4 they can survive. Survival and growth of curd isolates at low pH is significant 
because according to their characteristics of probiotic, can be applied for dairy industry as well as 
used in pharmaceutical aid.
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Graph: 3a, 3b and 3c shows curd, yoghurt and milk isolates survival and growth at different 
pH. It can be observed that each isolate can survive in pH 2 and pH3 while gives good growth at 
pH 4, pH5, pH6 and pH7. Only one yoghurt sample Yg1 fails to survive and grow at pH2 and pH3 
while all other isolates survives and gives growth that can be considered as significant character of 
isolate to act as probiotics. Because in intestinal tract acidic pH is there and isolates should survive 
from the entry and to establish in gut. Survival of milk bacteria in presence of acid is significant 
because in case of human, consumption of milk after birth colonizes stomach with friendly bacteria.
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Graph: 3d1 to 3d11: Growth of Stool Samples isolates at different pH
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Graph 3d1 to 3d11 Shows survival and growth of isolates S5b, S1,S2, SI, SII, RB-b, RB-c, 
RBII, RBIII, A and B at different pH. Graph shows that isolates S1, S2 and RBII fails to survive at 
pH 2 while all others isolates show survival at this pH. This finding can be justified by the fact that 
these isolates have intestinal origin (stool sample) where the pH range is from extreme acidic 
(stomach) to moderately acidic (intestine). Thus graph represents their true nature of survival and 
growth at low pH.
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Graph: 3e1 to 3e12: Growth of Vaginal Swab Samples isolates at different pH
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Graph: 3e1 to 3e12 shows Survival and Growth of Vaginal sample isolates at different pH. 
Graph Shows survival of each vaginal isolates at pH2, pH3 and pH4 as well as Good growth of at
different pH values. Vg2 and Vgf isolates only survive at pH 5 which can be observed From 3e11 
and 3e12. These findings can be justified by the fact that vaginal isolates must survive in low pH as 
their role is to protect vagina from the infection by maintaining and growing at low pH.
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3) GROWTH OF ISOLATES WITH  DIFFERENT NaCl CONCENTRATIONS
Study of growth pattern and characteristics of probiotics in presence of varying concentrations 
of NaCl was also carried out. This was performed to check the ability of the isolates to tolerate 
different NaCl concentrations during their residence in the intestine.
Graph: 4a, 4b & 4c: Growth of Curd, Milk and Yoghurt Sample isolates at different NaCl
concentrations
Graph 4a, 4b and 4c indicates that curd, milk and Yoghurt isolates not only survive but 
shows good growth in 1%, 2%, 3% and 4% (w/v) NaCl concentrations. As these isolates find their 
applications in dairy industry, their survival in presence of high salt concentration is very 
significant.
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Graph: 4d1 to 4d11: Growth of Stool Sample isolates at different NaCl concentrations
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Graph: 4d1 to 4d11 shows Survival and Growth of Stool sample isolates at different NaCl 
concentrations. Isolates S5b, S1,S2, SI, SII, RB-b, RB-c, RBII, RBIII, A and B give good and 
favourable growth at different NaCl concentrations. Isolates S1, S2, SI and SII show very less 
growth at 3% NaCl concentrations. This variation in the pattern of growth and survival in the 
presence of different salt concentratins can be attributed to them being the different strins.
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Graph: 4e1 to 4e12: Growth of Vaginal Samples isolates at different NaCl concentrations
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Graph: 4e1 to 4e12 shows Survival and Good Growth of Vaginal isolates at different NaCl 
concentrations. Isolates S5b, S1,S2, SI, SII, RB-b, RB-c, RBII, RBIII, A and B gives good and 
favourable growth at different NaCl concentrations. Survival and Growth in presence of NaCl 
shows that these organisms can combate the pathogens in vaginal region and can stop their 
establishment in presence of high salt concentrations due to glands present in skin.
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4) COMPARISION OF GROWTH OF ISOLATES WITH INULIN:
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Prebiotics are non-digestible food ingredients that stimulate the growth and/or activity of 
bacteria in the digestive system in ways claimed to be beneficial to health. The most common type 
of prebiotic is from the soluble dietary fibre inulin. Experiments were carried out to study the effect 
of presence of inulin on survival and growth of the selected isolates.
Graph 5a shows comparative study growth and survival of curd isolates, PC, Cua, Cub and 
Cuc in presence and absence of inulin. As prebiotic it is not directly incorporated for bacterial 
growth but assist for establishment and antimicrobial activity.From the graph it can be observed 
that presence of 0.5% and 1% inulin functions to enhance the growth. Milk Sample isolates Milk, 3 
and 1C shows different pattern, in which their growth in absence of inulun is high as compared to 
MRS + 0.5% Inulin and MRS + 1% Inulin. Changed pattern as compare to curd isolates indicates 
strain specificity.
Similarly growth of Yg2 is enhanced in presence of 1% Inulin as compare to Yg1 and Yg3, 
yoghurt isolates. Yg1 shows higher growth with 0.5% Inulin but not with 1% Inulin. This can be 
due to the changed metabolic patterns of these isolates.
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Graph: 5d1 to 5d11: Growth of Stool Sample isolates with different concentrations of inulin
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Graph: 5d1 to 5d11 Indicates enhanced growth of each stool sample isolates in presence of 
0.5% and 1% Inulin as compared to the growth in its asbsence. Isolates S5b, S1,S2, SI, SII, RB-b, 
RB-c, RBII, RBIII, A and B gives good and favourable growth in presence of inulin. This finding is 
of great significance as it indicates that administration of probiotics as therapeutics can be made 
more effective if the administration is done along with prebiotics
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Graph: 5e1 to 5e12: Growth of Vaginal Swab Sample isolates with different concentrations of 
inulin
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Graph: 5e1 to 5e12 Indicates enhanced growth of each vaginal isolate with 0.5% and 1% 
Inulin as compared to growth without it.Each at different Inulin concentrations gives good and 
favourable growth. As is discussed earlier, this finding is of great significance as it indicates that 
administration of probiotics as therapeutics can be made more effective if the administration is done 
along with prebiotics.
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ANTIBACTERIAL ACTIVITY OF ISOLATES
An important aspect of the function of probiotic bacteria is the protection of the host 
gastrointestinal microenvironment from invading pathogens. It is generally believed that the 
resident gastrointestinal microflora in vivo provides protection for the host against possible 
colonisation by pathogenic bacteria. (Reid G. et al., 1990)
Antibacterial activity of isolates was carried out on N-agar plates by well –diffusion 
assay against E.coli, E.aerogens, Salmonella, Pseudomonas species, S.aureus Bacillus
subtilis, Bacillus megaterium, & Bacillus cereus. Cultures were activated in N broth. CFC-
cell free extract of isolates inhibits the above mentioned organisms or not was studied and 
zone of inhibition was measured in terms of zone diameter and with the help of that zone 
index was calculated and graph prepared.
1) ANTIBACTERIAL ACTIVITY OF CURD SAMPLE ISOLATES:
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Graph 6a to 6h shows that all isolates have antimicrobial activity against E.coli, 
E.aerogens, Bacillus subtilis, Bacillus megaterium, Bacillus cereus , Salmonella, Shigella,
S.aureus and ,Pseudomonas species. S.aureus is more inhibited by PC. while contrastingly 
PC was unable to inhibit B.subtilis. Cub & Cuc were more inhibitory to E.aerogen. Cuc has 
given maximum zone of inhibition against S.typhi.B. Thus it can be interpreted that isolates.
Cuc can be used as food supplementary in the case of Typhoid infection.
Production of antimicrobial substances is another mechanism by which probiotics 
may protect against infections. Production of acidic metabolites such as lactic and acetic acid 
and the pH reductive effect is one example. (Servin A.L., et al., 2004)
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ANTIBACTERIAL ACTIVITY OF MILK SAMPLE ISOLATES:
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0
1
2
3
MILK 3 1C
Z
on
e 
In
d
ex
 (
m
m
)
Graph:7h
Antibacterial activity of milk 
sample isolates against 
Pseudomonas
Results and Discussion
88
Each isolates shows comparative inhibition pattern and from graph it can be observed 
that 1-C gives highest antimicrobial activity against S.aureus. While 3 gives maximum zone 
of inhibition against Pseudomonas and B.cereus. Milk cannot inhibit B.subtilis and Milk and 
1c both were unable to inhibit B.cereus.
From this it can be summarized that isolate 1-C can be more useful for treating and 
preventing respiratory infections. Lactobacillus spp. have demonstrated inhibition of growth of 
human pathogens due to acid production. (Servin AL. et al., 2004)
This study was conducted to determine the presence of antimicrobial activities among 
the probiotics incorporated into these different food products against common microbial 
pathogens. Substantiating the antimicrobial activities of probiotics will affirm their use in the 
development of functional foods for the betterment of the health of the consuming public.
2) ANTIBACTERIAL ACTIVITY OF YOGHURT SAMPLE ISOLATES:
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The study of antimicrobial activity of isolates from yoghurt sample varied. Yogurt 
isolates inhibits the growth of all organisms tested against them except B.cereus. Graph 
shows that Yg1 gives highest antibacterial activity against S.typhi para B. While Yg2 gives
maximum zone of inhibition with B.megaterium. This could be the reason for the beneficiary 
action of Yakult, Yogurt and curd. The results of the study indicates that probiotics are 
helpful in the protection and improvement of our intestinal flora. Consuming these products 
can help protect one from occurrences of diarrhea, food poisoning and even systemic and 
enteric infections. The verified antimicrobial activity of the probiotics supports the 
development of these functional foods as a key to the improvement of the health of the 
consuming public.
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3) ANTIBACTERIAL ACTIVITY OF STOOL SAMPLE ISOLATES:
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Antibacterial activity of stool sample isolates against E.coli
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Antibacterial activity of stool sample isolates against E.aerogens
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Antibacterial activity of stool sample isolates against B.cereus
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Antibacterial activity of stool sample isolates against B.megatarium
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Antibacterial activity of stool sample isolates against B.subtilis
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Graphs 9a – 9h shows result of the study of antimicrobial activity of stool samples 
against all the pathogens. Isolate B shows highest antimicrobial activity against S.aureus while 
RB-b & S2 can inhibit E.aerogen. B.subtilis could not be inhibited by isolates A & B. Ability 
of these isolates to inhibit the growth of pathogen could be useful for treating the 
gastrointestinal diseases. & isolate B could be used to treat enterotoxin produce by S.aureus.
The economic success and exciting prospects of probiotic products have accelerated research 
on intestinal lactobacilli. 
4) ANTIBACTERIAL ACTIVITY OF VAGINAL SAMPLE ISOLATES:
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Antibacterial activity of vaginal sample isolates against E.coli
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Antibacterial activity of vaginal sample isolates against E.aerogens
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Antibacterial activity of vaginal sample isolates against S.aureus
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Antibacterial activity of vaginal sample isolates against B.cereus
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Antibacterial activity of vaginal sample isolates against B.subtilis
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Antibacterial activity of the vaginal isolates against each test organisms was studied.
B.cereus is found to be inhibited by six vaginal isolates while other six were fail to inhibit it. 
Vag isolate shows maximum antimicrobial activity against B.megaterium. Vg6c shows highest 
zone of inhibition against E.aerogen. While Vg5e inhibits S.aureus. Results of vaginal isolates 
are very much important because of involvement of probiotics in treatment of the urinary tract 
infection. Maintenance or reconstruction of the normal composition of the vaginal microflora 
by applying properly selected Lactobacilli may be of prophylactic value in preventing or curing 
genitourinary system infections in women. 
When L. acidophilus is co-cultivated with other organisms, L. acidophilus has 
repeatedly been shown to inhibit the growth of competing microbes. It is thought that L. 
acidophilus produces a variety of antimicrobial compounds including organic acids, hydrogen 
peroxide, diacetyl and bacteriocins. The activity of these compounds is evident in the 
laboratory, but the in vivo role of these compounds is less clear. This is an area of active 
research. For instance, human fecal samples show a correlation between a reduction in pH and
an increase in short chain fatty acids with higher fecal counts of Lactobacilli and bifidobacteria
(which is another species that exhibits a probiotic effect). In the laboratory strain NCFM 
demonstrated antagonistic activity against common foodborne disease agents such as 
Staphylcoccus aureus, Salmonella typhimurium, and enteropathogenis Escherichia coli.
(Sanders M.E. et al., 2001)
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 E.coli by isolates for that Graph 11a shows each isolates were capable to inhibit E.coli. 
Vaginal isolates, Vg5b, Vg6a, Vg6b and Yg2 are more capable to inhibit E.coli as 
compare to others.
 Graph 11b indicates that each isolates gave good Antimicrobial activity against 
E.aerogen while S2, Vg6C, RB-b gave maximum activity. Stool samples & isolate 1-C 
give less zone of inhibition against E.aerogen. The activity of isolates against E.aerogen
prove that supplementary of this isolates can give strength to the immune system.
 Inhibition study of isolates for S. typhi illustrates that antimicrobial activity against 
S.typhi.B was comparative high, as isolates B &Yg1 gave Maximum activity. From this 
graph it can be concluded that isolates have ability to decrease the level of pathogenic 
bacteria in gastro intestinal tract.  & treating para typhoid diseses caused by S.typhi.B
 S.aureus Inhibition by B &Vg5e isolates shows Maximum inhibitory zone. Isolate Vg6a 
also shows significant inhibition against S.aureus. Isolates have ability to inhibit 
S.aureus to treat enterotoxin diseses. 
 Inhibition of Bacillus spp. By isolates can open up new line of research in this field. All 
isolates gave antimicrobial activity while Vag gave maximum activity while other 
isolates has also given zone of inhibition against B.megaterium.
 As compare to other organisms, B.cereus inhibition spectrum was quite different as 
isolates were giving antimicrobial activity against B.subtilis but RB-b & RB- II gave 
maximum activity. Vg6a, Vg6c, vg2, Milk, A & B isolates cannot inhibit B.subtilis.
Inhibition of  Bacillus spp. By this indication of new path of research is there by isolates. 
Isolates.
 Against Pseudomonas all isolates gave antimicrobial activity but Vg5b gave maximum 
 activity. P. aeruginosa is one of the organism as discussed above that its inhibition by 
probiotics is significant.
Thus from the study of antibacterial activity of isolates obtained from different 
samples that their applications in the field of biology may show new horizons and isolates 
could be useful as a supplementary which work in harmony with the different tissues and 
organ cells to metabolize proteins and aid to get rid of poisonous excesses from our body.
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STUDY OF GROWTH PATTERN OF ISOLATES
On the basis of obtained results of previously discussed experiments SII and Vg5b were 
selected for study of growth pattern. 
As Shown in Graph 12, SII growth pattern indicates maximum growth in presence of 
MRS + 1% bile salt as compared to MRS without bile. Same can be said for its comparison 
with MRS + pH3. Result reveals that actual nature of isolate is intestinal tract where 
presence of bile seems to be helping in survival and growth of probiotics.
Growth pattern of Vg5b is quite similar to SII. Difference is change in pattern of 
growth obtained with only MRS agar medium.  Graph 13 shows that after the 7hr growth of 
Vg5b in MRS medium shows rise in optical density which may indicate log phase and later
followed by stationary phase at 14hrs. While in Vg5b also maximum growth is obtained with 
MRS + 1% Bile salt as compared to only MRS and MRS + pH3.
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Comparative study of growth pattern of isolates with and without supplement of 
(1%w/v) inulin:
1) Graph 14a to 14e: Comparative study of growth pattern of Stool sample 
isolates with and without inulin.
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Graph 14a to Graph 14e represents Pattern of growth of stool sample isolates in 
presence and absence of inulin. It can be concluded from graph that there is similarity in the 
pattern of growth observed in presence and in absence of inulin. Each graph represents that 
stool sample isolates have long Lag phase up to 5 hrs and then there is rise in growth known 
as log phase where growth rate is high as compare to other growth phases and then stability 
of growth represents culture has been reached to stationary phase. Decreasing the Optical 
density of the culture is indication of decline phase but proper decline phase cannot be 
obtained by colorimetric method as dead cells also contribute for optical density. Thus as 
little decrease obtained in O.D., experiment was terminated. To study decline growth phase,
simultaneous viable count method can be useful.
2) Graph 15a to 15k: Comparative study of growth pattern of Stool sample 
isolates with and without inulin
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Above graphs of Vaginal Swab sample isolates shows growth pattern of isolates with 
and without inulin have more or less similar pattern.
Difference observed for each isolates was that there with stationary phase in which in 
presence of inulin as compare to absence of inulin was quite earlier. It means pattern of 
growth is similar up to log phase and lag phase but difference is observed with stationary 
phase which was earlier. Reason may require more experimental proof but one possibility is 
that as antimicrobial substance production is there when stationary phase is achieved and this 
may directly assisting for the production of antimicrobial substances.
Several oligosaccharides, such as IMO, FOS, GOS, inulin, and lactulose have been 
reported to significantly enhance the growth of desirable bacteria such as bifidobacteria and 
lactobacilli. (Kneifel et al., 2000; Pennacchia et al., 2006) The results of the present study
showed that the each probiotic strains were capable to grow in presence of inulin examined
but the growth varied little among the species and strains.
These prebiotics would have the potential to increase the population and activity of 
these probiotic strains in the gastrointestinal tract when administered in the form of synbiotic, 
and thus enhance their beneficial effects on the host. Further investigation in vivo is needed to 
determine the efficacy of the synbiotic and whether it could provide a twofold synergistic 
effect on the host.
Role of prebiotic as supplement with probiotic is one of the most recent concept for 
the preparation of supplements of probiotic with antibiotic and its recolonization after such 
antibiotic treatments, not as only enhancement for growth of probiotics but even for assisting 
in the antimicrobial activity. The functional benefits of synbiotic, such as resistance to 
gastrointestinal bacterial infection, antimicrobial activity, and improvement of immune 
system are envisaged in the development of synbiotic products. In recent years, studies have 
shown that synbiotic has the potential to be an alternative to antibiotic as a growth promoter 
for broilers. (Mohnl et al.,2007; Jung et al., 2008; Awad et al., 2009)
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COMPARATIVE STUDY OF GROWTH PATTERN AND ANTIBACTERIAL 
ACIVITY IN PRESENCE AND IN ABSENCE OF 1 %( w/v) INULIN.
Graph: 16a to 16h: Comparison of Growth and Its Antibacterial activity of S5b
Above graph 16a and 16b shows growth and antibacterial activity of S5b in presence 
and absence of inulin. Graph 16a represents inhibition of E.coli is greater by the application 
of inulin and similar pattern observed for E. aerogens from Graph 16b, that may indicates 
presence of E.coli as in gut when act as opportunistic pathogen this probiotics can inhibit 
them. Graph illustrates inhibition of isolates enhances when inulin is added as supplement of 
medium. Which illustrates that prebiotics assists for enhancement of antibacterial activity and 
in gut also favours colonization. 
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Above graph 16c and 16d shows growth and antibacterial activity of S5b in presence 
and absence of inulin against Salmonella typhosa B and against S. aureus respectively. 
Inhibition pattern is different but similar in the way that at initial stages of growth with inulin 
comparative high inhibition is obtained.  Graph illustrates inhibition of isolates enhances 
when inulin is added as supplement of medium.  Many researches have focused on the 
inhibition of infection of Salmonella and simultaneous application of probiotics to cure with 
application of medicines.
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Above graph 16e and 16f shows growth and antibacterial activity of S5b in presence 
and absence of inulin against Bacillus spp. Graph illustrates inhibition of isolates enhances 
when inulin is added as supplement of medium. Which illustrates that prebiotics assists for 
enhancement of antibacterial activity and in gut also favours colonization. Inhibition pattern 
is quite similar against B.megaterium.
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Graph 16g and 16h represents growth and antibacterial activity of S5b in presence and 
absence of inulin against B.subtilis and Pseudomonas. There are many of the researches 
carried out for study of inhibition to pseudomonas by probiotics. Graph illustrates inhibition 
of isolates enhances when inulin is added as supplement of medium. For Pseudomonas after 
14 hours no inhibition is obtained with MRS + inulin while that remains as it is up to 18 
hours with only MRS. Contrastingly growth pattern does not affected. This reveals new 
aspect to understand inulin effect for inhibition. 
All above graphs represents inhibition spectrum of S5b in presence and absence of 
inulin and it can be observed that S5b is capable to inhibit each organisms and its inhibition 
can be enhanced by application of inulin.
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Graph: 17a to 17h: Comparison of Growth and Its Antibacterial activity of S1
Graph 17a and 17b represents growth in presence and absence of inulin and 
antibacterial activity of S1 against E.coli and E.aerogens.
Inhibition of E.coli is quite comparable in presence and in absence of inulin and that 
can be observed from the graph but inhibition of E.aerogens is obtained with only MRS not 
when MRS is supplemented with inulin which is contrasting characteristic and required 
further research with this aspect.
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Similar pattern to Graph 17b is obtained with 17c in which the inhibition of 
Salmonella is not obtained with supplement of inulin while inhibition of S.aureus from graph 
17 d represents that at the starting phase of growth is high as compare to stationary phase.
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Graph 17e and Graph 17f represents inhibition spectrum of SI against Bacillus where 
inhibition on application of inulin is enhanced and both Bacillus cereus and Bacillus 
megaterium are inhibited with and without application of inulin.
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Graph 17g and Graph 17h represents antibacterial activity of S1 against B.subtilis and 
against Pseudomonas. Antibacterial activity of graph 17g is similar to previous two graphs 
while for pseudomonas inhibition difference is obtained with application of inulin that 
inhibition is started after 10 hours. This pattern may be there because Stationary phase is 
related with production of inhibitory substance production. 
Above all graph 17a to 17h represents that S1 is capable to inhibit each organism but 
pattern vary in presence and in absence of inulin. 
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Graph: 18a to 18h: Comparison of Growth and Its Antibacterial activity of S2
Above both graph of S2 for comparison of growth and antibacterial activity in 
presence of inulin shows greater inhibitory action for both E.coli and E.aerogens. Graph 18 a 
shows antibacterial activity initiated earlier of S2 with Inulin as compare to only MRS. For 
E.aerogens also Inhibition achieved only with inulin.
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Contrast is created in Graph 18c and in Graph 18d because as compare to Graph 18a 
and Graph 18b in both of this growth remains unaffected much more but inhibition is not at 
all achieved with Inulin supplemented medium. Inhibition of Salmonella is significant aspect 
for intestinal gut bacteria but with this isolate that is not enhanced or activated with prebiotic 
like inulin. 
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Graph 18e and Graph 18 f represents inhibition of Bacillus spp. and comparative 
study of growth of S2 in presence and in absence of inulin. Pattern was more or less similar 
for growth and inhibition of bacillus spp. obtained by isolates have nearer to same patter with 
inulin as compare to only MRS.
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Graph 18g of S2 for growth and inhibition of B.subtilis shows inhibition is there 
starting from 2hrs to 18hrs of growth and with consistency while that is there with MRS 
supplement of inulin but that consistency is not there with MRS only, which shows 
antibacterial activity throughout the growth curve and required after colonization in gut. 
Graph 18 h represents S2 growth and inhibition of Pseudomonas, and contrasting to previous 
here only with MRS antibacterial activity is obtained.
Above all graph represents that S2 is capable to inhibit each organism but pattern is 
varied with application to inulin.
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Graph: 19a to 19h: Comparison of Growth and Its Antibacterial activity of SI
Graph 19a represents Growth pattern of SI in presence and in absence of Inulin which is quite 
similar while antibacterial activity is differentiated as with application of inulin starting from 
2hrs inhibition was obtained against E.coli and this may be useful as application of Probiotic 
and Prebiotic as combination Synbiotic to compete with E. coli. Totallly different to that is 
that this isolate is not at all inhibitory to E. aerogens with and without Inulin.
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S.typhi inhibition as shown in Graph 19c is constant with MRS while also obtained 
with MRS + Inulin but not consistant. SI is capable to inhibit S.typhi B. SI study of 
comparative inhibition of S.aureus shows that broth with inulin does not capable to inhibit at 
all while MRS broth only is capable to inhibit. Which represents their strain specificity and 
capability to grow and inhibit in presence and absence of inulin.
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Bacterial Species Bacillus inhibited by isolates SI with variety of inhibitory pattern 
and here for both B.cereus and B.megaterium stability is observed only there with MRS broth 
without supplement of inulin.
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Graph 19g represents inhibition of B.subtilis with SI and is obtained as similar with 
Graph 19e and Graph 19f. While Pseudomonas inhibitory pattern of isolate is interesting as 
in absence and in presence both are nearer to same except with inulin inhibition is not 
obtained after 18hour or even at 18 hour and that inhibition is obtained with MRS broth.
Inhibition pattern of isolate SI is quite different than other as that do not inhibit 
E.aerogens and inhibition to each bacillus spp. were more or less similar shows strain 
specificity of isolate.
0
0.5
1
1.5
2
2.5
3
3.5
0
0.5
1
1.5
2
2.5
3
3.5
2 4 6 8 10 12 14 16 18
Z
on
e 
In
de
x
O
.D
 a
t 5
40
 n
m
Time in hours
Graph:19g
Comparison of Growth and its Antibacterial Activity  of SI Against 
B.subtilis in Presence and in Absence  of  1%(w/v) inulin
Growth Growth(Inulin) B.subtilis  Inhibition(Inulin) B.subtilis Inhibition
0
0.5
1
1.5
2
2.5
3
3.5
0
0.5
1
1.5
2
2.5
3
3.5
2 4 6 8 10 12 14 16 18
Z
on
e 
In
de
x
O
.D
 a
t 5
40
 n
m
Time in hours
Graph:19h
Comparison of Growth and its Antibacterial Activity  of SI Against 
Pseudomonas in Presence and in Absence  of  1%(w/v) inulin
Growth Growth(Inulin) Pseudomonas Inhibition(Inulin) Pseudomonas  Inhibition
Results and Discussion
119
Graph: 20a to 20h: Comparison of Growth and Its Antibacterial activity of SII
Graph 12 a represents Growth of SII in presence and in absence of inulin and pattern does not 
affected. E.coli inhibition pattern is different as after 10 hrs there is no inhibition observed for 
isolate SII and for E.aerogens inhibition was only obtained with MRS broth.
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SII antibacterial activity pattern is totally different for inhibition of S.typhi B and not 
constant up to 18 hrs for broth with inulin while stability of antibacterial activity is obtained 
in inhibition of S.aureus where up to the 18 hrs starting from 2hrs constant inhibition pattern 
is obtained. To cure staphylococcal infection SII might be the significant probiotic isolate.
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Graph 20e indicates inhibition of B.cereus enhances after 10 hrs when broth is 
supplemented with inulin while for antibacterial activity against B,megaterium as shown in 
graph 20 f stability is obtained with MRS broth.
0
0.5
1
1.5
2
2.5
3
3.5
0
0.5
1
1.5
2
2.5
3
3.5
2 4 6 8 10 12 14 16 18
Z
on
e 
In
de
x
O
.D
 a
t 5
40
 n
m
Time in hours
Graph:20e
Comparison of Growth and its Antibacterial Activity  of SII Against 
B.cereus in Presence and in Absence  of  1%(w/v) inulin
Growth Growth(Inulin) B.cereus  Inhibition(Inulin) B.cereus Inhibition
0
0.5
1
1.5
2
2.5
3
3.5
0
0.5
1
1.5
2
2.5
3
3.5
2 4 6 8 10 12 14 16 18
Z
on
e 
In
de
x
O
.D
 a
t 5
40
 n
m
Time in hours
Graph:20f
Comparison of Growth and its Antibacterial Activity  of SII Against 
B.megaterium in Presence and in Absence  of  1%(w/v) inulin
Growth Growth(Inulin) B.megaterium Inhibition(Inulin) B.megaterium Inhibition
Results and Discussion
122
Graph 20g and Graph 20 h represents different pattern of antibacterial activity and 
constant inhibition is obtained in graph 20 h against pseudomonas when MRS broth is used 
while after 12 hours there is no inhibition obtained when MRS broth + inulin studied for 
antibacterial activity. S II is able to inhibit each isolate with varied pattern and its 
antibacterial activity was enhanced by application of inulin.
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Graph: 21a to 21h: Comparison of Growth and Its Antibacterial activity of VaR2
Vaginal isolate’s antibacterial activity is significant as to study urinary tract infection 
and role of lactobacillus- probiotic present in that acidic pH. Pattern of growth shows log 
phase up to 5 hours followed by short log phase and long stationary phase where antibacterial 
activity is obtained.
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Graph 21c represents growth of vaginal isolate VaR2 in presence and in absence of 
Inulin with their antibacterial activity against salmonella and graph reveals that no inhibition 
is obtained when MRS is supplemented with inulin while after 12 hr that may be at the end of 
stationary pahse inhibition is obtained for salmonella which is striking characteristic of 
isolate and contrasting to that for S.aureus inhibition is obtained in broth supplemented with
inulin after 8hrs that may be the starting of stationary phase.
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Graph 21e represents Antibacterial activity against B.cereus of Var2 with inulin 
stopped after 12hrs and contrasting to it Graph 21 represents antibacterial activity against 
B.megaterium shows stability up to 14hrs and decrease was observed with MRS broth after 
12 hrs. 
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Graph 21g and Graph 21h represents growth and antibacterial activity of VaR2 
vaginal swab sample isolate with and without inulin against B.subtilis and Pseudmonas 
respectively. Isolate is capable to inhibit B.subtilis as well as Pseudomonas with varied 
pattern.
Vaginal swab sample isolate was capable to inhibit each organism used with varied 
pattern. Antibacterial activity of isolate can be enhanced on the application of inulin.
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Graph: 22a to 22h: Comparison of Growth and Its Antibacterial activity of Vag
Graph 22a represents Growth of Vag and its antibacterial activity against E.coli.
Graph revels the growth pattern was remain as it is when inulin was supplied it was not 
affected but when observation of antibacterial activity focused at that time interestingly no 
inhibition was found that may be because of colonization of probiotic in gut does not affect 
normal flora or any other mechanism of support is there, which widens new thinking areas. 
Graph 22b represents inhibition of E.aerogens was there with and without inulin and no 
enhancement is there when broth is supplemented with inulin.
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Graph 22c represents growth and antibacterial activity of Vag and when broth was 
supplemented with inulin Vag was capable to inhibit Salmonella and this inhibition is 
significantly lasts for 14hrs. Graphs 22d represent antibacterial activity of Vag against 
S.aureus and remain up to 14hrs when broth is supplemented with inulin. This may be 
because of the reason that prebiotic directly does not support growth but enhances their 
activity.
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Bacillus spp. can be inhibited by vaginal swab sample isolate can be observed from 
Graph 22e and 22f. Graph 22e shows that supplement of inulin has not affected much 
antibacterial activity against B.cereus while affected much against B.megaterium. 
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Graph 22g reveals that after 8 hrs inhibition was there against B.subtilis whith 
supplement of inulin as well as without supplement of inulin. Graph 22 h represents 
Antibacterial activity of vaginnal swab sample isolate known as Vag against Pseudomonas 
enhanced when broth was supplemented with inulin but remains up to 14 hrs while for MRS 
broth only stablility was observed up to 14 hours.
Graph 22a to 22h represents antibacterial activity of Vag which was quite differ than 
other isolate as this was not inhibitory to E.coli.
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Graph: 23a to 23h: Comparison of Growth and Its Antibacterial activity of Vg5b
Graph 23 a and 23 b represents that Vg5b growth pattern was remains unchanged in 
presence and in absence of inulin. Vg5b Antibacterial activity obtained only with MRS and 
isolate unable to inhibit when MRS + Inulin supplemented, inhibition of E.coli was obtained 
after 6 hours while E.aerogens inhibition was started after 12 hours.
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Graph 23 c represents Antibacterial activity was not obtained at all against S.typhi B, 
which reveals strain specificity and Graph 23 d reveals that Vg5b able to inhibit S.aureus
when MRS broth was used but when it was supplemented with inulin it was unable to inhibit 
S.aureus.
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Graph 23 e shows that Vg5b was capable to inhibit B.cereus in presence and in 
absence of inulin and inhibition was quite consistent but that consistency was not obtained for 
inhibition of B.megaterium in which stability remains in medium when supplemented with 
inulin but not in MRS broth only.
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Graph 23 g and Graph 23 h represents that Vg5b was capable to inhibit B.subtilis as 
well as Pseudomonas. Supplement of inulin to the MRS broth may assist bacteria not by 
growth promoter aspect but may enhance antibacterial activity and consistency of activity.
Graph 23 a to 23 h  represents growth pattern in presence and in absence of inulin and 
antibacterial activity.
0
0.5
1
1.5
2
2.5
3
3.5
0
0.5
1
1.5
2
2.5
3
3.5
2 4 6 8 10 12 14
Z
on
e 
In
de
x
O
.D
 a
t 5
40
 n
m
Time in hours
Graph:23g
Comparison of Growth and its Antibacterial Activity  of Vg5b 
Against B.subtilis  in Presence and in Absence  of  1%(w/v) inulin
Growth Growth(Inulin) B.subtilis  Inhibition(Inulin) B.subtilis Inhibition
0
0.5
1
1.5
2
2.5
3
3.5
0
0.5
1
1.5
2
2.5
3
3.5
2 4 6 8 10 12 14
Z
on
e 
In
de
x
O
.D
 a
t 5
40
 n
m
Time in hours
Graph:23h
Comparison of Growth and its Antibacterial Activity  of Vg5b 
Against Pseudomonas  in Presence and in Absence  of 1%(w/v)  inulin
Growth Growth(Inulin) Pseudomonas Inhibition(Inulin) Pseudomonas  Inhibition
Results and Discussion
135
Graph: 24a to 24h: Comparison of Growth and Its Antibacterial activity of Vg5c
Graph 24 a and 24 b represents Antibacterial activity and growth of Vg5c in presence 
and in absence and it was clear that it even assist for growth. Antibacterial activity was not 
found significant against both E.coli and E.aerogens. As a gut flora may not inhibition 
obtained against these organisms.
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Graph 24 c and Graph 24 d represents that Vg5c not able to inhibit Salmonella and
S.aureus significantly. This antibacterial activity is strain specific and may be is not there 
with Vg5b.
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Graph 24 e and 24 f shows that compared to inulin absent broth with inulin 
isolates were giving high zone and after 2hrs only and Vg5b was not able to inhibit E.coli, 
E.aerogens,  STB and S.aureus inhibiting Bacillus spp. That may be the strain or genus 
specific inhibition characteristic or organism.
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Graph 24 g and 24 h reveals that Vg5b is capable to inhibit in presence and in absence 
of inulin. Pseudomonas was inhibited significantly by Vg5b.
Antibacterial activity of Vg5b was very contrasting for organism to organism and that 
strain specificity was useful when one is interested to treat any particular infection caused by 
one organism.
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Graph: 25a to 25h: Comparison of Growth and Its Antibacterial activity of Vg5d
Graph 25 a and 25 b represents antibacterial activity of Vg5d and growth pattern in 
presence and in absence of inulin, where for both graph inhibition against E.coli and 
E.aerogens started after 8hrs with MRS broth. For E.coli inhibition was obtained at initial 
hours in broth with MRS which was not found constant. Graph 25 b reveals that inhibition 
started after 8hrs and that may be related with growth phase as at that time culture was 
entering in stationary phase.
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Graph 25 c reveals that inhibition was significant in broth supplemented 
with inulin after 10 hrs and with MRS only started at initial phase that may according to its 
strain specific characteristic. Graph 25 d shows inhibition was not found at all in presence 
and in absence of inulin. Thus, Vg5d was not able to inhibit S.aureus. Vaginal swab sample 
isolates were studied for their significant antibacterial activity.
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Graph 25 e and 25 f represents that long lag phase is followed by log phase for the 
growth of Vg5b. Inhibition is constant when Antibacterial activity studied with application of 
inulin.
Thus, it can be observed that inulin enhances the antibacterial activity of isolates.
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Graph 25g and 25h represents vaginal swab sample Vg5d inhibition spectrum vary 
with hour to hour but specifically inhibition of Bacillus spp. was obtained. Vaginal swab 
sample able to inhibit Bacillus subtilis as well as Pseudomonas. 
As compare to other vaginal swab sample isolate Vg5d does not have significant 
antibacterial activity.
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Graph: 26a to 26h: Comparison of Growth and Its Antibacterial activity of Vg5e
Graph 26a and Graph 26b represents Growth and Antibacterial activity of Vg5e 
against E.coli and E.aerogen. Vg5e growth pattern suggest that long lag phase followed by 
short log phase and followed by little long stationary phase. While antibacterial activity was 
quite significant against E.coli but was not significant against E.aerogens.
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Graph 26 c represents Vg5e was able to inhibit S.typhi B significantly as compare to 
Graph 26d inhibition of S.aureus. Inhibition of S.aureus initiated after 10hrs and that is also 
there with MRS broth when supplemented with Inulin.
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Vaginal swab sample isolate Vg5e represents that this isolate have 
antibacterial activity against B.cereus and B.megaterium in presence and in absence of inulin.
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Graph 26g reveals inhibition by Vg5e to B.subtilis in presence and in absence of 
inulin. Graph 26h represents that Pseudomonas inhibition was quite significant when medium 
was supplemented with inulin. Vg5e shows diversified inhibition spectrum and even growth 
was enhanced when medium was supplemented with inulin.
Above all results reveals that Stool sample and Vaginal sample isolates shows 
significant effect when medium was supplemented with Inulin. Growth was enhanced when 
medium was supplemented of isolates with inulin. As well as enhancement of antibacterial 
activity was observed. 
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STUDY OF GROWTH OF AND  ANTIBACTERIAL ACTIVITY  OF ISOLATES IN 
PRESENCE OF BILE
Graph: 27 represents growth of stool sample isolates and vaginal swab sample 
isolates. Graph indicates that Vg5e growth is highest with 1% bile salt concentration While 
VaR2 grows maximally with 2% bile salt concentration, growth of VaR2, Vag and S2 is quite 
comparable at 3% bile salt concentration. While at 4% bile salt concentration maximum 
growth is obtained by VaR2, Vag and Vg5e. Moreover, Graph represents that Stool sample 
isolates were unable to grow maximally as compare to vaginal swab sample isolates.
Survival of probiotic isolate in presence of bile and their favourable growth is 
significant to colonize in gut but simultaneous significant character of probiotic is its 
antibacterial activity. Presence of antibacterial activity is carried out with MRS broth but it 
should be there in presence of bile, because in vivo bile is present.
Thus this study is carried out to know whether antibacterial activity is there with bile 
salt or not and for that 1%, 2%, 3% and 4% Bile salt (w/v) containing MRS broth is used. 
Inhibition of organisms is recorded by zone index measurement.
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Graph 28 a Represents that antibacterial activity of stool sample isolates is quite less as 
compare to vaginal swab sample isolates, may be the reason is their growth is also not so high 
as compare to vaginal swab sample isolate. S2 and SII were able to inhibit E.coli at 2% and 
4% bile salt concentration. VaR2, Vg5b and Vg5e represents highest inhibition at 1% bile salt 
concentration While Vg5d and Vag were able to inhibit at only three different concentration. 
And Vg5c is not capable to inhibit at all E.coli. As intestinal flora – normal flora E.coli 
inhibition is not desirable but it is opportunistic pathogen and thus its inhibition by probiotic 
shows significance according to health of host.
Graph 28 b Represents inhibition of E.aerogens by each isolate. Only one, S5b is
capable to inhibit E.aerogens at 1% bile salt concentration while other any isolates were not 
able to inhibit E.aerogens with different bile salt concentration. VaR2 and Vg5b showss 
inhibition of E.aerogens at 1% and 4% bile salt concentration, while Vg5e shows inhibition 
at 2%, 3% and 4% bile salt concentration. Vag, Vg5c and Vg5d were not able to inhibit 
E.aerogens. 
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Graph 28 c represents antibacterial activity of isolates against S.typhi B in presence of 
different bile salt concentrations. SI, SII, Vg5c were unable to inhibit S.typhi B while S5b, 
VaR2, Vag, Vg5d inhibits at different three concentrations and S2 inhibits only at one 
concentration. S1, Vg5b and Vg5e were able to inhibit S.typhi B at 1%,2%, 3% as well as at 
4% concentrations.
Graph 28 d represents inhibition of S.aureus by antibacterial activity of each isolates 
in presence of bile salt.  Graph reveals that S5b, Vag, Vg5b, Vg5c and Vg5d were unable to 
inhibit while S1, SI, Vg5e inhibits at each bile salt concentrations S2, SII, and VaR2 were 
only able to inhibit at 1% and 2% bile salt concentrations.
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Antibacterial activity of isolates against S.typhi B with different bilesalt 
concentration
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Graph 28 c represents antibacterial activity of isolates against B.megaterium in 
presence of different bile salt concentrations. Only SII is able to inhibit B.megaterium and 
Vg5b, Vg5d and Vg5e inhibits at each concentrations and Vg5c inhibits only at one 
concentration. VaR2 and Vag able to inhibit B.megaterium at three different concentrations.
Graph shows that vaginal swab samples were capable to inhibit B.megaterium as compare to 
stool sample isolates.
Graph 28 d represents that isolates were not so capable to inhibit B. cereus in presence 
of bilesalt. S5b, S1 S2 shows that inhibition is there but only at with single concentration of 
bile salt while in vaginal swab sample isolates also Vg5b is the only one isolate with which 
inhibition obtained. This reveals the strain specific characteristic as well as their ability to 
inhibit typical organism.
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Antibacterial activity of isolates against B.megaterium with different 
bilesalt concentration
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Graph 28g and 28h reveals that Stool sample isolates were not able to inhibit 
B.subtilis and Pseudomonas. S2 and SII with 2% bile salt concentration were able to inhibit 
Pseudomonas. As compare to that vaginal swab sample isolates were more efficient to inhibit 
organisms.
From all above graph it is clear that in presence of bile Isolates shows Antibacterial 
activity. In presence of bile as compare to stool sample, vaginal swab sample were quite more 
efficient to inhibit organisms. As a probiotic their survival, growth were significant to study 
but with that also study of antibacterial activity is an important aspect. Still this study is in 
vitro. Further in vivo probiotic isolates survival and antibacterial activity study is required to 
be performed.                      
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STUDY OF GROWTH AND ANTIMICROBIAL ACTIVITY OF STOOL AND 
VAGINAL SWAB SAMPLE ISOLATE AT pH 3.
Graph 29 a and 29 b represents Growth and Antibacterial activity of Stool sample 
isolate SII against E.coli and E.aerogens respectively. Inhibition in presence of acid, or at low 
pH is very significant as probiotics colonize in gut and in that condition it inhibits E.coli that 
may act as opportunistic pathogen and inhibition assist to compete against pathogen,
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Graph 29c and Graph 29 d represents shows antibacterial activity against S.typhi B
and S. aureus respectively. Salmonella inhibition is an important aspect as it is infectious 
agent and its inhibition suggests that this probiotic isolates may apply to cure salmonella
infection. S.aureus inhibition pattern suggests that it starts from 2hrs and remain constant up 
to last.
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Growth and Antibacterial Activity  of SII Against S.typhi B at pH 3
O.D at 540nm in MRS broth with pH 3 Antibacterial activity against S.typhi B
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Graph 29 e and Graph 29 f represents antibacterial activity against Bacillus spp.
Graph reveals that inhibition obtained against Bacillus cereus and Bacillus megaterium was 
quite constant, stabile inhibitory spectrum starts after 2hrs and lasts up to the last reading.
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Growth and Antibacterial Activity  of SII Against B.cereus at pH 3
O.D at 540nm in MRS broth with pH 3 Antibacterial activity against B.cereus
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Graph 29g and Graph 29h represents antibacterial activity against Bacillus subtilis
and Pseudomonas respectively. Pseudomonas inhibition is an important aspect as it is 
infectious agent and its inhibition suggests that this probiotic isolates may apply to cure its 
infection. 
Stool sample isolate SII able to inhibit each organism at pH3. As probiotic isolate it 
proves that it can grow at low pH and even shows inhibitory action. Still study was carried 
out in vitro, thus in vivo study required.
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Graph 30a and Graph 30 b represents shows antibacterial activity against E.coli and 
E.aerogens respectively. E.coli inhibition is an important aspect as it is infectious agent and 
its inhibition suggests that this probiotic isolates may apply to cure infection. E.coli inhibition 
pattern suggests that it starts from 2hrs and remain constant up to last.
0
5
10
15
20
25
30
0
0.05
0.1
0.15
0.2
0.25
2hr 3hr 4hr 5hr 6hr 7hr 8hr 9hr 10hr 11hr 12hr 13hr 14hr 15thr 16hr
Z
on
e 
In
de
x
O
.D
 a
t 5
40
 n
m
Time in hours
Graph:30a
Growth and Antibacterial Activity  of Vg5b Against E.coli
at pH 3
O.D at 540nm in MRS broth with pH 3 Antibacterial activity against E.coli
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Graph 30c and Graph 30 d represents shows antibacterial activity against S.typhi B
and S. aureus respectively. Salmonella inhibition is an important aspect as it is infectious 
agent and its inhibition suggests that this probiotic isolates may apply to cure salmonella
infection. S.aureus inhibition pattern suggests that it starts from 2hrs and remain constant up 
to last.
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Graph:30c
Growth and Antibacterial Activity  of Vg5b Against S.typhi B
at pH 3
O.D at 540nm in MRS broth with pH 3 Antibacterial activity against S.typhi B
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Graph 30 e and Graph 30 f represents shows antibacterial activity against B.cereus
and B.megaterium respectively. B.cereus inhibition pattern suggests that it starts from 2hrs 
and remain constant up to last. B.megaterium also inhibited by vaginal swab sample isolate 
Vg5b at pH3.
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Graph 30 g and Graph 30 h represents shows antibacterial activity against B.subtilis
and Pseudomonas respectively. Pseudomonas inhibition is an important aspect as it is 
infectious agent and its inhibition suggests that this probiotic isolates may apply to cure its
infection. Pseudomonas inhibition pattern suggests that it starts from 2hrs and maximum at 
11hrs.
The acidity of gastric juice, which is determined as hydrochloric acid concentration, 
influences the viability of probiotic strains, which manifests in different modes, depending on 
bacterial strains.
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ANTIBACTERIAL PROTEIN PURIFICATION 
From the stool & vaginal isolates the crude protein was separated by ammonium 
sulphate precipitation method. These different fractions were then dialysed & from them 
SDS-PAGE were performed.
40% of Vg5b, 60% of SII, V g5b and S5b were loaded in SDS PAGE and seperation 
occur is shown in figure. Lane Marker indicates the molecular weights of the protein marker 
in kDa.
The molacular size of all the different fraction of isolates SII, Vg5b,& S5b was 
determined to be between 100Kda to 50Kda by comparing it with the protein molecular 
marker having precisely sized ranged from 10Kda to 225Kda. 
Antimicrobial activity of isolates against many of pathogenic bacteria may result in 
the discussion that isolates produces bacteriocin like substances which further can be studied 
by its purification.
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ANTIBIOTIC SUSCEPTIBILITY TEST
Table: 11 Gram-Positive Discs
       N0. Name of Antibiotics    Symbol Concentration(µg/ml)
1
Clindamycin
Cm 2
2
Telcoplanin
Tp 10
3
Lomefloxacin
Lf 5
4
Moxifloxacin
Mf 5
5
Ampicilinsalbactum
AS -
6
Cefaclor
CG 30
7
Cefadroxll
CD 30
8
Roxithyromycin
Ro 30
9
Clarithromycin
CL 15
10
Lincomycin
LN 15
11
Sparfloxin
Sp 5
12
Gatifloxacin
GF 15
13
Linezolid
Li 30
14
Vancomycin
Vm 30
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Table: 12 (a) Antibiotic Susceptibility of Isolates (Gram positive disc)
Isolates
Gram Positive Disc
Cm/
2
Tp/10 Lf/5 Mf/5 AS
CG/
30
CD/
30
Ro/3
0
CL/
15
LN/
15
Sp/5
GF/
15
Li/3
0
Vm/
30
Pc S R S R S S S S S S S S R R
Cub R R R R R R R R R R R R R S
Cuc R R R R R R R R R R R R R R
Cue R R R S R R R R R R R S R R
S5b S S S R S S R S S S S S S S
S1 R R R R R R R R R R R R R R
S2 R R R R R R R R R R R R R R
S-I S R R R S R S S S R S R R R
S-II S R R S R S S S S S S S S R
RB-b R R R R R R R R R R R R R R
RB-c R R R S R R R R R R S R R R
RB-II R S S S R R R S R R S S S S
RB-III R R R R S R R R R R R R R R
Yg1 R S R R R R R R R R R R R R
Yg2 R R R R R R R R R R R R R R
Yg3 R R R R R R R R R R R R R R
A R R R R R R R R R R R R R R
B R R R R R R R R R R R R R R
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Table: 12 (b) Antibiotic Susceptibility of Isolates (Gram positive disc)
Isolates
Gram Positive Disc
Cm/2 Tp/10 Lf/5 Mf/5 AS CG/30 CD/30 Ro/30 CL/15 LN/15 Sp/5 GF/15 Li/30 Vm/30
VaR2 R R S S S R S S R R S S S R
Vag R S S S S R S R R R S S S S
Vg5b R S S S R S R S R R R R R R
Vg5c R S S R R R S S R R R R R R
Vg5d R S S S R R S R S S S R R S
Vg5e R R R R R R S R R R R R R R
Vg6a R R R R R R R R R R R R R R
Vg6b S S S S S S S S S S S S S S
Vg6C R R S S S R R R R R R S R R
Vg1 R R R R R R R R R R R R R R
Vg2 R R R R R R R R R S R R R S
Vgf R R R R R R R R R R R R R R
MILK R R R S R R R R R R R S R R
3 R R R R R R R R R R R S R R
1C S R R R S R S R R R R R R R
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Table 12 (a) shows the number of strains for each species observed to be S and R to 
the antibiotic tested. PC, S5b, SII and RB II shows sensitivity toward many antibiotics while 
others are resistant.
Table 12 (b) shows the number of strains for each species observed to be S and R to 
the antibiotic tested. VaR2, Vag and Vg6b shows sensitivity toward many antibiotics while 
others are resistant.
Table: 13 Gram-Negative Discs
N0. Name of Antibiotics Symbol Concentration(µg/ml)
1 Norfloxacin NF 10
2 Aztr AT 30
3 Cefotaxime CX 30
4 Nalidixic acid NA 30
5 Nitrofurantoi FU 300
6 Cefuroxime CR 30
7 Gentamycin GM 10
8 Amikacin AK 30
9 Ciprofloxain CI 5
10 Ofloxacin OF 5
11 Ceftazidime CZ 30
12 Cefdinir CN 5
13 Ceftriaxone FR 30
14 Cefixime FX 5
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Table: 14 (a) Antibiotic Susceptibility of Isolates (Gram negative disc)
Table 14 (a) shows the number of isolates be S and R to the antibiotic tested. Most of isolates 
were resistant towards many antibiotics.
Isolates
Gram-Negative disc
NF/10 AT/30 CX/30 NA/30 FU/300 CR/30 GM/10 AK/30 CI/5 OF/5 CZ/30 CN/5 FR/30 FX/5
Pc R R S R R R R R R R S R S R
Cub R R R R R R R R R R R R R R
Cuc R R R R R R S S R R R R R R
Cue R R R R R R S S R R R S R R
S5b R R R R R R R R R R R R R R
S1 R R R R R R R R R R R R R R
S2 R R R R R R S R R R R S S R
S-I R R R R S R R R R R R R R R
S-II R R R R R R S S R R R R R R
RB-b R R R R R R S R R R R R R R
RB-c R R R R R R R R R R R R R R
RB-II R R R R R R R R R R R R R R
RB-III R R R R R R R R R R R R R R
Yg1 R R R R S R S R R R R R R R
Yg2 S R R R R R R R S R R R R R
Yg3 S R S R S S S R S S R R S R
A R R R R R R R S R R R R R R
B R R R R R R R R R R R R R R
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Table: 14 (b) Antibiotic Susceptibility of Isolates (Gram negative disc)
Table 14 (b) shows the number of isolates be S and R to the antibiotic tested. Most of 
isolates were resistant towards many antibiotics and that may be due to the use of multi 
antibiotic disc was specifically of Gram negative discs. As isolates were Gram Positive most 
of the species were resistant and shows growth with many antibiotics.
Isolates
Gram-Negative disc
NF/
10
AT/
30
CX/
30
NA/
30
FU/3
00
CR/
30
GM/
10
AK/
30
CI/
5
OF/
5
CZ/
30
CN/
5
FR/
30
FX/
5
VaR2 R R R R R R S R R R R R R R
Vag R R R R R R R S S R R R R R
Vg5b R R R R R R R R R R R R S R
Vg5c R R R R R R R R R R R R R R
Vg5d R R R R R R R R R R R R R R
Vg5e R R R R R R R R R R R R R R
Vg6a R R R R R R R R R R R R R R
Vg6b R R R R R R R R S R R R R R
Vg6C R R R R R R S R R R R R R R
Vg1 R R R R R R R R R R R R R R
Vg2 R R R R R R R R R R R R R R
Vgf R R R R R R R R R R R R R R
MILK R R R R R R R R R R R R R R
3 R R S R R R R R S R R R S R
1C R R R R R R R R R R R S R R
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ANTIBIOTIC SUSCEPTIBILITY TEST
Similar results were obtained by D.H. Tambekar, Multiple antibiotic resistance 
indicating high resistance to all antibiotics. (Tambekar D.H. et al., 2010) 
Such resistance to a wide spectrum of antibiotics indicated that if isolated probiotics 
induced in patients treated with antibiotic therapy may be helpful in faster recovery of the 
patients due to rapid establishment of desirable microbial flora. Resistance of the probiotic 
strains to some antibiotics could be used for both preventive and therapeutic purposes in 
controlling intestinal infections. (EI-Naggar, 2004)
Many of the earlier studies only concentrated on the resistance phenotypes and thus 
may have had problems in interpreting borderline resistance cases. Again, this may 
complicate safety determinations and present regulatory drawbacks if such a "borderline" 
antibiotic resistance has been determined for a particular strain, but none of the typical 
resistance genes could be identified, leading to confusion as to whether this resistance is 
acquired and/or transferable.
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IDENTIFICATION OF ISOLATES BY 16s rRNA: 
(CARRIED OUT AT GSBTM-GANDHINAGAR)
No. Isolate 
name
sample 
id
Identified Organism BAB No. GenBank 
Accession No.
1 Vag 2 Lactobacillus fermentum BAB-1356 JN815020
2 Vg5b 3 Enterococcus faecium BAB-1357 JN815021
3 Vg5c 4 Lactobacillus fermentum BAB-1358 JN815022
4 Vg5d 5 Enterococcus durans BAB-1359 JN815023
5 Vg5e 6 Pediococcus pentosaceus BAB-1360 JN815024
6 Vg6a 7 Enterococcus faecium BAB-1361 JN815025
7 Vg6b 8 Enterococcus durans BAB-1362 JN815026
8 Vg6c 9 Enterococcus 
durans/faecium
BAB-1363 JN815027
9 Vg2 11 Enterococcus durans BAB-1365 JN815028
10 Vgf 12 Enterococcus durans BAB-1366 JN815029
11 RB-b 18 Enterococcus                           
durans/faecium
BAB-1372 JN815030
12 RB-c 19 Enterococcus faecalis BAB-1373 JN815031
13 RBII 20 Enterococcus 
durans/faecium
BAB-1374 JN815032
14 A 22 Enterococcus faecalis BAB-1376 JN815033
15 B 23 Pediococcus pentosaceus BAB-1377 JN815034
16 PC 24 Pediococcus pentosaceus BAB-1378 JN815035
17 Cub 25 Lactobacillus fermentum BAB-1379 JN815036
18 Cuc 26 Enterococcus durans BAB-1380 JN815037
19 Milk 28 Lactobacillus fermentum BAB-1382 JN815038
20 3 29 Lactobacillus fermentum BAB-1383 JN815039
21 1-C 30 Pediococcus pentosaceus BAB-1384 JN815040
22 Yg-2 32 Lactobacillus fermentum BAB-1386 JN815041
23 Yg-3 33 Enterococcus durans BAB-1387 JN815042
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On the basis of the experiments performed, results obtained and literature survey, following 
conclusions have been found:
• Probiotics are the normal flora of intestinal tract and can be obtained from various Natural 
samples like Milk, Curd, and Yoghurt as well as from stool sample and vaginal swab sample.
• Probiotics have ability to produce antimicrobial agents which protect internal organs 
especially intestinal tract and vaginal tract from infection. 
• The Antibacterial substance produces by Probiotics seems to be a Protein of high molecular 
weight.  
• Antibiotics susceptibility shows resistance of isolates towards various antibiotics which is a 
significant character of probiotics.
• Resistance of the probiotic strains to antibiotics could be used for both preventing and 
therapeutic purpose in controlling intestinal infection.
• Isolates survival and growth at low pH ( pH 2 – 7) suggest that they can survive in extreme 
condition of intestinal tract.
• Growth in presence of Bile (1 – 4%) (w/v) indicates bile tolerance of isolates and the 
possibility of these organisms to be administered orally,.
• Experimental results showed that isolates are able to tolerate NaCl (1 – 4%) 
(w/v)concentration. NaCl adapted isolates can help to survive in simulated gastric fluid. This 
indicates that it may be  useful in enhancement of the stability and functional properties of 
probiotic strains.
• Property of tolerance to bile, acidic pH and NaCl concentrations could be advantageous for a 
probiotic culture for successful colonization in gastrointestinal environment.
• Prebiotics- non digestible but supportive to probiotic growth shows enhanced growth                                            
pattern of probiotics when combined with them. Study of possible mechanism of probiotics 
activity and their association with prebiotics may lead to the development of novel probiotics 
with new therapeutic aspectsotics.
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• Lactobacillus fermentum, Enterococcus durans, Pediococcus pentosaceus, Enterococcus 
faecium, Enterococcus durans/faecium, Enterococcus faecalis were the isolates obtained 
from different natural samples and identified by partial 16srRNA sequence as probiotics.
• Probiotics isolated from different samples were different from each other which was proved 
by 16s rRNA sequence, this could be because of the different in the role that they have to 
play in those samples.
• Construction or development of a highly potent probiotics consortium suitable to function 
under stress and adverse condition can be of great value as therapeutics and can be 
comparable with commercially available products.
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